SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 10-Q



[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended June 30, 2015


[  ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT


For the transition period from ____________ to____________


Commission File No. 000-50547


SUNDANCE STRATEGIES, INC.

(Exact name of Registrant as specified in its charter)


Nevada

88-0515333

(State or Other Jurisdiction of

(I.R.S. Employer Identification No.)

incorporation or organization)

  


4626 North 300 West, Suite No. 365

Provo, Utah 84604

(Address of Principal Executive Offices)


(801) 705-8968

(Registrant’s telephone number, including area code)


N/A

(Former name, former address and former fiscal year,

if changed since last report)


Indicate by check mark whether the Registrant has (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [X] No [  ]


Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).  Yes [X] No [  ]


Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):


Large accelerated filer [  ]      Accelerated filer [X]       Non-accelerated filer [  ]      Smaller reporting company [  ]


Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ] No [X]





APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS


Indicate by check mark whether the Registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.


Not applicable.


APPLICABLE ONLY TO CORPORATE ISSUERS


Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latest practicable date: August 10, 2015 – 44,128,441 shares of common stock.


NAME REFERENCES


In this Quarterly Report, references to the “Registrant,” “Sundance Strategies,” the “Company,” “we,” “our,” “us” and words of similar import, refer to “Sundance Strategies, Inc.,” the Registrant, and where applicable, include the current and intended business operations of ANEW LIFE, INC., a Utah corporation and our wholly-owned subsidiary (“ANEW LIFE”), our acquisition of which, by merger, occurred on March 29, 2013.  


FORWARD-LOOKING STATEMENTS


This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Quarterly Report. These factors include, but are not limited to, economic conditions generally in the United States and internationally and in the industry and markets in which we have and may participate in the future, competition within our chosen industry, our current and intended business, our assets and plans, the effect of applicable United States and foreign laws, rules and regulations on our business and our failure to successfully develop, compete in and finance our current and intended business operations.


You should read any other cautionary statements made in this Quarterly Report as being applicable to all related forward-looking statements wherever they appear in this Quarterly Report. We cannot assure you that the forward-looking statements in this Quarterly Report will prove to be accurate, and therefore, prospective investors are encouraged not to place undue reliance on forward-looking statements. You should read this Quarterly Report completely, and it should be considered in light of all other information contained in the reports or registration statement that we file with the Securities and Exchange Commission (the “SEC”), including all risk factors outlined therein.  Most recently, a list of risk factors was outlined in our 10-K Annual Report for the fiscal year ended March 31, 2015, and filed with the SEC on June 15, 2015, on pages 25 though 39 thereof, which is referenced in Part II, Item 6, below.  Other than as required by law, we undertake no obligation to update or revise these forward-looking statements, even though our situation may change in the future.




2





JUMPSTART OUR BUSINESS STARTUPS ACT DISCLOSURE


We qualify as an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act by the Jumpstart Our Business Startups Act (the “JOBS Act”). An issuer qualifies as an “emerging growth company” if it has total annual gross revenues of less than $1.0 billion during its most recently completed fiscal year, and will continue to be deemed an emerging growth company until the earliest of:


 

the last day of the fiscal year of the issuer during which it had total annual gross revenues of $1.0 billion or more;


 

the last day of the fiscal year of the issuer following the fifth anniversary of the date of the first sale of common equity securities of the issuer pursuant to an effective registration statement;


 

the date on which the issuer has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or


 

the date on which the issuer is deemed to be a “large accelerated filer,” as defined in Section 240.12b-2 of the Exchange Act.


As an emerging growth company, we are exempt from various reporting requirements. Specifically, we are exempt from the following provisions:


 

Section 404(b) of the Sarbanes-Oxley Act of 2002, which requires evaluations and reporting related to an issuer’s internal controls;


 

Section 14A(a) of the Exchange Act, which requires an issuer to seek shareholder approval of the compensation of its executives not less frequently than once every three years; and


 

Section 14A(b) of the Exchange Act, which requires an issuer to seek shareholder approval of its so-called “golden parachute” compensation, or compensation upon termination of an employee’s employment.


Under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards that have different effective dates for public and private companies until such time as those standards apply to private companies.  We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.






3




PART I


Item 1.  Financial Statements


The Condensed Consolidated Financial Statements of the Company required to be filed with this Quarterly Report were prepared by management and commence below, together with related notes. In the opinion of management, the Condensed Consolidated Financial Statements fairly present the financial condition of the Company and include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s Condensed Consolidated Financial Statements. The results from operations for the three month period ended June 30, 2015, are not necessarily indicative of the results that may be expected for the fiscal year ended March 31, 2016. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the March 31, 2015, Consolidated Financial Statements and footnotes thereto included in the Company’s Form 10-K Annual Report for the fiscal year ended March 31, 2015, which was filed with the SEC on June 15, 2015, and which is referenced in Part II, Item 6, below.


SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)


 

Page(s)

 

 

Condensed Consolidated Balance Sheets as of June 30, 2015 and March 31, 2015

5

 

 

Condensed Consolidated Statements of Operations for the Three Months Ended June 30, 2015 and 2014

6

 

 

Condensed Consolidated Statements of Cash Flows for the Three Months Ended June 30, 2015 and 2014

7

 

 

Notes to the Condensed Consolidated Financial Statements

8 - 13





4





SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Balance Sheets

June 30, 2015 and March 31, 2015

(Unaudited)

 

 

June 30,

 

March 31,

 

 

2015

 

2015

ASSETS

Current Assets

 

 

 

 

Cash and Cash Equivalents

$

        21,951

 

$

      336,370

 

Prepaid Expenses

 

                 -

 

 

      1,875

 

 

 

 

 

 

 

Total Current Assets

 

     21,951

 

 

  338,245

 

 

 

 

 

 

 

Other Assets

 

 

 

 

 

 

Investment in Net Insurance Benefits

 

  23,368,665

 

 

  22,544,635

 

Advance for Investment in Net Insurance Benefits

 

  3,834,033

 

 

3,596,386

 

Notes Receivable

 

    211,000

 

 

    211,000

 

Other

 

    27,875

 

 

 16,428

Total Other Long-term Assets

 

 27,441,573

 

 

   26,368,449

Total Assets

$

  27,463,524

 

$

  26,706,694

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities

 

 

 

 

 

 

Accounts Payable

$

  349,351

 

$

    255,361

 

Accrued Expenses

 

      4,296

 

 

     181,917

 

Notes Payable

 

           -

 

 

   1,326,876

 

Note Payable-Related Party

 

          -

 

 

   1,500,000

Total Current Liabilities

 

 353,647

 

 

  3,264,154

 

 

 

 

 

 

 

Long-Term Liabilities

 

 

 

 

 

 

Note Payable-Related Party

 

 1,875,000

 

 

      -

 

Convertible Debenture

 

   700,000

 

 

    -

 

Accrued Expenses

 

   50,444

 

 

          -

Total Long-Term Liabilities

 

  2,625,444

 

 

           -

Total Liabilities

 

 2,979,091

 

 

   3,264,154

 

 

 

 

 

 

 

Temporary Equity

 

 

 

 

 

 

Contingently Redeemable Common Stock

 

    750,000

 

 

            -

 

 

 

 

 

 

 

Stockholders' Equity

 

 

 

 

 

 

Preferred Stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding

 

      -

 

 

             -

 

Common Stock, authorized 500,000,000 shares, par value $0.001; 44,222,191 and 43,185,941 shares issued and outstanding, respectively

 

  44,222

 

 

       43,186

 

Additional Paid In Capital

 

23,954,163

 

 

   16,316,882

 

Additional Paid In Capital- Stock to be Issued

 

            -

 

 

    7,540,000

 

Accumulated Deficit

 

   (263,952)

 

 

   (457,528)

Total Stockholders' Equity

 

  23,734,433

 

 

  23,442,540

Total Liabilities and Stockholders' Equity

$

  27,463,524

 

$

   26,706,694

 

The accompanying notes are an integral part of these condensed consolidated financial statements.




5





SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statements of Operations

For the Three Months Ended June 30, 2015 and 2014

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Three Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2015

 

2014

 

 

 

 

 

 

 

 

 

Interest Income on Investment in Net Insurance Benefits

 

$

   824,030

 

$

    563,498

 

 

 

 

 

 

 

 

 

General and Administrative Expenses

 

 

    595,954

 

 

    616,366

 

 

 

 

 

 

 

 

 

Income (Loss) from Operations

 

 

   228,076

 

 

    (52,868)

 

 

 

 

 

 

 

 

 

Other Income (Expense)

 

 

 

 

 

 

 

Interest Income

 

 

     4,702

 

 

       4,342

 

Interest Expense

 

 

   (39,202)

 

 

    (16,141)

 

   Other, net

 

 

         -

 

 

      6,303

 

 

 

 

 

 

 

 

 

Total Other Expense

 

 

    (34,500)

 

 

      (5,496)

 

 

 

 

 

 

 

 

 

Income (Loss) Before Income Taxes

 

 

 193,576

 

 

    (58,364)

 

Income Tax Provision

 

 

          -

 

 

            -

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

$

  193,576

 

$

    (58,364)

 

 

 

 

 

 

 

 

 

Basic and Diluted:

 

 

 

 

 

 

 

Basic Earnings (Loss) Per Share

 

$

             -

 

$

      (0.01)

 

Diluted Earnings (Loss) Per Share

 

$

          -

 

$

(0.01)

 

 

 

 

 

 

 

 

 

 Basic Weighted Average Number of Shares Outstanding

 

 

 43,433,750

 

 

  43,015,941

 

Diluted Weighted Average Number of Shares Outstanding

 

 

 44,826,040

 

 

    43,015,941

 





The accompanying notes are an integral part of these condensed consolidated financial statements.




6





SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statements of Cash Flows

Three Months Ended June 30, 2015 and 2014

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Three Months Ended

 

 

 

 

June 30,

 

June 30,

 

 

 

 

2015

 

2014

 

 

 

 

 

 

 

 

 

Operating Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss)

$

     193,576

 

$

    (58,364)

 

Adjustments to reconcile to cash from operating activities:

 

 

 

 

 

 

 

Share Based Compensation - Options

 

   98,317

 

 

    104,150

 

 

Advance for Investments in Net Insurance Benefits

 

   (237,647)

 

 

  (553,557)

 

 

Accrued Interest Income

 

   (11,447)

 

 

        4,198

 

 

Prepaid Expenses

 

      1,875

 

 

            -

 

 

Accounts Payable

 

    93,990

 

 

   47,053

 

 

Accrued Expenses

 

      45,947

 

 

        1,298

 

 

Investment in Net Insurance Benefits

 

 (824,030)

 

 

   (563,498)

 

 

 

 

 

 

 

 

 

 

     Net Cash from Operating Activities

 

    (639,419)

 

 

   (1,018,720)

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from Notes Receivable

 

      -

 

 

  550,000

 

 

 

 

 

 

 

 

 

 

     Net Cash from Investing Activities

 

      -

 

 

  550,000

Financing Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from Issuance of Notes Payable-Related Party

 

   375,000

 

 

     100,000

 

Proceeds from Issuance of Convertible Debenture

 

     700,000

 

 

          -

 

Redemption of Temporary Equity

 

   (750,000)

 

 

              -

 

 

 

 

 

 

 

 

 

 

     Net Cash from Financing Activities

 

    325,000

 

 

     100,000

 

 

 

 

 

 

 

 

Net Change in Cash

 

 (314,419)

 

 

   (368,720)

Cash at Beginning of Period

 

   336,370

 

 

   375,212

 

 

 

 

 

 

 

 

 

Cash at End of Period

$

      21,951

 

$

          6,492

 

 

 

 

 

 

 

 

 

Non Cash Financing Activities

 

 

 

 

 

 

 

Cash Paid for Interest

$

              -

 

$

         -   

 

 

Notes Receivables Exchanged for Advance for Investment in NIBs

$

               -

 

$

     100,000

 

 

Exchange Note Payable and Accrued Interest for Temporary Equity

$

    1,500,000

 

$

                -   





The accompanying notes are an integral part of these condensed consolidated financial statements.



7




 

SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

June 30, 2015


(1) ORGANIZATION AND BASIS OF PRESENTATION


The condensed consolidated unaudited interim financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q and do not contain information included in the Company’s annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the March 31, 2015, audited consolidated financial statements and the accompanying notes thereto. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company’s consolidated condensed financial statements and accompanying notes. Actual results could differ materially from those estimates.  These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented.


Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies,” the “Company” or “we”). The Company is a specialty financial services company which is engaged in the secondary market for life insurance known generally as “life settlements.” Currently, the Company is focused on the purchase of net insurance benefit contracts (“NIB”) on life insurance policies between the sellers and purchasers, but does not take possession or control of the policies. The purchasers acquire the life insurance policies at a discount to their face value for investment purposes. The purchasers have available credit to pay premiums and expenses on the underlying policies until settlement. On settlement, the Company receives the NIB after all borrowings, interest and expenses have been paid out of the settlement proceeds.


(2) NEW ACCOUNTING PRONOUNCEMENTS


In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2014-09 – Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This ASU is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2016. Early adoption is not permitted, and companies can transition to the new standard under the full retrospective method or the modified retrospective method. The Company does not believe adoption of this ASU will have a material impact on its financial statements.


In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The new standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s financial statements.




8




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

June 30, 2015


(2) NEW ACCOUNTING PRONOUNCEMENTS (Continued)


In April, 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs (Subtopic 835-30). This update requires debt issuance costs to be presented in the balance sheet as a direct deduction from the associated debt liability. Under current standards, debt issuance costs are generally recorded as an asset and amortization of these deferred financing costs is recorded in interest expense. Under the new standard, debt issuance costs will continue to be amortized over the life of the debt instrument and amortization will continue to be recorded in interest expense. ASU 2015-03 is effective for the Company on January 1, 2016, and will be applied on a retrospective basis. The Company is currently evaluating the impact this guidance will have on our consolidated financial statements.


The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.


(3) INVESTMENT IN NET INSURANCE BENEFITS


As of the three months ended June 30, 2015 and the fiscal year ended March 31, 2015, investments in NIBs were as follows:


 

June 30, 2015

 

March 31, 2015

Beginning Balance

 $                22,544,635

 

 $            12,243,411

Additional investments

                                  -   

 

                 7,846,746

Accretion of interest income

                        824,030

 

                 2,454,478

Distributions of investments

               -  

 

                             -   

Impairment of investments

              -  

 

                             -   

Total

 $                23,368,665

 

 $            22,544,635


The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance contracts that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance (“MRI”).  Future expected cash flow is defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment and service provider or other third-party payments.  The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company’s balance sheet does not increase when premiums or other expenses are paid.   The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of June 30, 2015 and March 31, 2015.     


The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company.  At the time of purchase of an investment in NIBs, we estimate the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our initial investment. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations.   Subsequent to the purchase and on a regular basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion.  Any positive or adverse change in cash flows that does not result in the recognition of an “other-than-temporary impairment” (“OTTI”) results in a prospective increase or decrease in the effective interest rate used to recognize interest income.  We have not recognized any significant adverse change in future estimated cash flows relating to our investment in NIBs from January 31, 2013 (inception) to the periods ended June 30, 2015.






9




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

June 30, 2015


(3) INVESTMENT IN NET INSURANCE BENEFITS (continued)


We evaluate the carrying value of our investment in NIBs for impairment on a regular basis and, if necessary, adjust our total basis in the NIBs using new or updated information that affects our assumptions.  We recognize impairment on a NIB contract if the expected discounted cash flows are less than the carrying amount of the investment, plus anticipated undiscounted future premiums and direct external costs, if any. We have not recognized any impairment on our investment in NIBs from January 31, 2013 (inception), to the periods ended June 30, 2015.


In estimating these cash flows for purposes of interest income and impairment calculations, there are a number of assumptions that are subject to uncertainties and contingencies. These include the amount and timing of projected net cash receipts, expected maturity events, counter party performance risk, changes to applicable regulation of the investment, shortage of funds needed to maintain the asset until maturity, changes in discount rates, life expectancy estimates and their relation to premiums, interest and other costs incurred, among other items. These uncertainties and contingencies are difficult to predict and are subject to future events that may impact our estimates and interest income. As a result, actual results could differ significantly from those estimates.


(4) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS


On June 7, 2013, the Company entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar Financial, S.a.r.l. (“Del Mar”). The Del Mar ATA involved the purchase of certain life settlement assets consisting of 100% of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the “NIBs”), among other assets that are consideration and collateral for certain cash advances and expense payments made by the Company. The original end result of the Del Mar ATA and the advance was not to purchase the NIBs provided as collateral, but instead to provide sufficient capital to Del Mar for the conversion of a portion of the NIBs and other potential NIBs into “Qualified NIBs.”  The original due date for the conversion was December 31, 2013, which date has subsequently been extended several times, with the most recent extension to August 31, 2015.  The conversion can be accepted by the Company upon receipt of a combined face amount of $400,000,000 of “Qualified NIBs,” meaning that the NIBs would have premium financing secured for up to five years; that any grouping of NIBs would have not less than 10 policies; that the average age of the insureds under the life insurance policies would be approximately 81 years; and that the NIBs would have mortality re-insurance coverage. All remaining NIBs that are not converted to “Qualified NIBs” and all other assets conveyed to the Company as collateral to assure delivery of the Qualified NIBs are to be re-conveyed to Del Mar upon receipt of combined Qualified NIBs having a face amount equal to $400,000,000.  


During January 2014, the Company completed with Del Mar the closing of Qualified NIBs with associated death benefits of $90.6 million for $5,436,000. These Qualified NIBs are part of the $400,000,000 commitment.


During December 2014, Del Mar refunded $904,274 advanced from the Company because of Del Mar’s delay in delivering the remaining portions of the $400,000,000 Qualified NIBs commitment.  The refund is recorded as a reduction of Advance for Investment in Net Insurance Benefits.


On April 30, 2015, the Company finalized an amendment to the Del Mar ATA and the related “Europa Agreement” (as defined below) to extend the deadline until August 31, 2015.  The extension is intended to give the Company time to work towards a settlement agreement with Del Mar, as it appears unlikely that Del Mar will be able to fulfill its obligation to deliver the remaining $309,400,000 in Qualified NIBs.  During this extension period, management will work toward a dissolution and resolution of the Del Mar ATA.


At June 30, 2015, the Company held collateral against the cash advances and expense payments made by the Company to Del Mar.  The collateral includes NIBs associated with life settlement policies with a face value that originally totaled $94,000,000. During June, 2015, one of the life settlement policies matured for $10,000,000, lowering the remaining face value of life settlement policies to $84,000,000 at June 30, 2015. The premiums and expenses related to the maintenance of these life insurance policies are financed by a loan from a senior lender. 





10




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

June 30, 2015


(4) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (continued)


In the likely event Del Mar is unable to provide the Qualified NIBs by the extended due date of August 31, 2015, the Company will have the option of selling collateral up to a liquidated damages settlement payment equal to 100% of any cash payments made under the Del Mar ATA. If the full balance of Qualified NIBs is provided by Del Mar, the Company will have paid $20,000,000 of consideration, $8,000,000 of which would be in cash and the remaining $12,000,000 in promissory notes. Promissory notes may be issued, pro rata, as Qualified NIBs are received. The promissory notes have a two year term from the effective date and bear an interest rate of 4.0% per annum. Total interest and principal amounts are due upon maturity.


As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (respectively, the “Europa Agreement” and “Europa”). The Company is required to pay a structuring fee of 1% of the face amount of the life insurance policies underlying all NIBs introduced by Europa and acquired by the Company, payable as follows: 50% of the fee on the delivery of the NIBs; and the remaining 50% being payable on the conversion of the NIBs to Qualified NIBs as defined in the Del Mar ATA. The total restructuring fee will be up to $4,000,000. In the event that any cash consideration by the Company under the Del Mar ATA exceeds the defined $8,000,000 cash threshold, the amount payable under the Europa Agreement will be reduced on a dollar for dollar basis for any such overage. The total purchase price will not exceed $24,000,000 under the Del Mar ATA, which is comprised of $12,000,000 in cash consideration and $12,000,000 in promissory notes.


On October 29, 2013, the Company and Europa, with the agreement of Del Mar, amended the Europa Agreement and the Del Mar ATA to acknowledge that the total up-front cash payment due from the Company under the Del Mar ATA and Europa Agreement shall not exceed $12,000,000; that the Company would receive a credit on a dollar for dollar basis of the cash payment and all costs and expenses paid under the Del Mar ATA over $8,000,000, against all fees due Europa under the Europa Agreement or the Del Mar ATA. In the event the Qualified NIBs delivered are less than $300,000,000 in face value under the Del Mar ATA Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA   and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by the Company, multiplied by two; and if at least $300,000,000 in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within 90 days.


Also on October 29, 2013, the Company entered into an Exclusivity Agreement with the consultant to Europa under the Europa Agreement under which the Company advanced $25,000 to such consultant for services related to the purchase of Qualified NIBs associated with the $400,000,000 in life insurance policies due under the Del Mar ATA.


(5) NOTE PAYBALE AND LINE-OF-CREDIT RELATED PARTY


As of June 30, 2015, the Company has borrowed $1,500,000, from an entity which is a stockholder in the Company, under a combined note payable and Line-of-Credit Agreement that allows for borrowings of up to $2,130,000 through September 30, 2016, at which time principal and interest is due in full.  The note payable and line-of-credit incurs interest at 7.5 percent and is collateralized by Advance for Investment in NIBs.  


During the three months ended June 30, 2015, the Company borrowed $375,000 from a stockholder and Board member.   The borrowing terms were formally finalized on July 22, 2015 (see Note 9).




11




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

June 30, 2015


(6) NOTES PAYABLE TRANSFERRED TO TEMPORARY EQUITY


At March 31, 2014, the Company owed $1,455,904, including accrued interest for notes payable.  During the year ended March 31, 2015, the Company had accrued an additional $37,350 in interest.  The note incurred interest at 4%, was collateralized by NIBs and was due April 2015.  During the three months ended June 30, 2015, the note payable and related accrued interest was converted to temporary equity through the issuance of 187,500 shares of common stock with a redemption feature (See Part II, Item 5, below).  On June 9, 2015, the holder of the redemption feature, exercised a portion of the redemption right relating to 93,750 shares and, as a result, the holder accepted the Company’s redemption payment of $750,000.  The redemption feature on the remaining 93,750 shares was originally eligible to be exercised by the holders on October 31, 2015, and is currently in negotiation to be extended to September 30, 2016.  


(7) CONVERTIBLE DEBENTURE AGREEMENT


On June 2, 2015, the Company entered into an 8% Convertible Debenture Agreement that allows for borrowings of up to $3,000,000 through September 30, 2016, at which time principal and interest is due in full. On June 2, 2016, the holder can elect to convert the outstanding principal and accrued interest to unregistered, restricted common stock of the Company.  The number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company’s common stock from the date the notice of conversion is received.  During June, 2015 the Company drew $700,000 under the agreement. Management has concluded there is currently no beneficial conversion feature associated with this instrument, as the conversion date is a year after the agreement was initiated and is also contingent.


(8) LIQUIDITY AND CAPITAL REQUIREMENTS


Under the current business plan, the Company purchases life insurance policies and residual interests in or financial products tied to life insurance policies when they fit its model and its cash flows are sufficient to fund those purchases (with exception of the Del Mar ATA wherein the Company committed to purchase a certain number of Qualified NIBs as Del Mar made them available).  The Company expects to finance NIB purchases, as well as its operating working capital requirements, with proceeds from planned public and/or private offerings of its securities and debt financing. There can be no assurance that the Company will be successful in the anticipated equity and debt offerings or that it will be successful in raising additional capital in the future on terms acceptable to the Company, or at all.


If the Company is unable to raise sufficient capital through the planned securities and debt offerings or other alternative sources of financing, management will curtail NIB purchases. Under this plan, expenditures for NIBs will be curtailed. The Company believes that it will be able to fund its operating working capital requirements with existing lines-of-credit and debentures agreements.


The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business. To continue as a going concern beyond the year ended March 31, 2016, and in order to continue to purchase NIBs, the Company will need to complete planned securities and debt offerings or obtain alternative sources of financing. Absent additional financing, the Company will not have the resources to execute its current business plan.


(9) SUBSEQUENT EVENTS


On July 22, 2015, the Board of Directors approved an amendment to modify the vesting schedule for stock options issued to an executive.  The amendment clarified that the option to purchase 400,000 shares of the Company’s $0.001 par value common stock at $5.00 per share, with a five year term, expiring March 31, 2018, was at a vesting rate of 11,111 stock options monthly, commencing with October, 2013 and ending with September 30, 2016, subject to continued employment with the Company.  As a result of this modification, the Company revalued the options on July 22, 2015, and arrived at a fair value of $528,023.  Up through June 30, 2015, the Company had previously



12




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

June 30, 2015


(9) SUBSEQUENT EVENTS (continued)


amortized $452,443 in expense relating to the options. The difference between the new valuation and the previously expensed amount will be amortized over the remaining 2.3 years of the life of the options.


On July 22, 2015 the Company entered into a Line-of-Credit agreement with a related party, stockholder and Board member that allows for borrowings of up to $1,115,000.  The note incurs interest at 7.5 percent, allows for origination fees, has a due date of September 30, 2016, or at the immediate time when the anticipated raise in equity funds is successful, and is collateralized by Advance for Investment in NIBs.  During the three months ended June 30, 2015, the Company borrowed $375,000, and subsequent to June 30, 2015, the Company drew an additional $190,000 on the Line-of-Credit, for a total of $565,000 drawn on the Line-of-Credit as of the date of this filing.


During July, 2015, a group of persons located in the United States (the “Purchasers”) acquired the entities that owned all of the portfolios of life insurance contracts underlying the Company’s NIBs.  The Company was supportive of the purchase because it believes this ownership change will result in a reduction of costs and expenses associated with ownership of the NIBs, which should increase their intrinsic value.  The Purchasers have also agreed to amend the NIBs agreements to provide greater disclosure to the Company and limit permitted expenses to be paid prior to payments to the NIBs holders, pending certain regulatory and tax approvals.  In connection with this purchase, the Purchasers and the respective owners of these portfolios entered into a Settlement Agreement releasing such owners and their managers from liability related to their ownership and management of the entities that owned the respective portfolios of life insurance contracts.  The Purchasers further required releases from the Company and the payment of certain accrued expenses.  Accordingly, effective as of July 17, 2015, the Purchasers acquired all of the ownership interests in the entities that owned all of the portfolios of life insurance contracts underlying the Company’s NIBs from their prior owners and executed a Settlement Agreement with such owners and the Company in relation to these matters.  The NIBs amendments are in process, and the Company believes the NIBs amendments will be in effect within the next six months. The Company and Purchasers agreed to indemnify the prior owners of such portfolios against future claims in connection with the issuance of the NIBs or their ownership or management of the entities sold, based on actions that occurred prior to this sale to the Purchasers.  Management of the Company is presently not aware of the existence of any such claims.  Neither the purchase of these entities nor the Settlement Agreement resulted in any material change in our NIBs ownership interest.


During July, 2015, the Company amended the 8% Convertible Debenture Agreement (see Note 7) to reflect that the price at which the Debenture may be converted will be no lower than $1.00 per share.



13




Item 2. Management’s Discussions and Analysis of Financial Condition and Results of Operations.


Forward-looking Statements


When used in this Quarterly Report, the words “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” and similar expressions are intended to identify forward-looking statements regarding events, conditions, and financial trends that may affect our future plans of operations, business strategy, operating results, and financial position. Persons reviewing this Quarterly Report are cautioned that any forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties and that actual results may differ materially from those included within the forward-looking statements as a result of various factors. Such factors are discussed further below under “Trends and Uncertainties,” and also include general economic fac tors and conditions that may directly or indirectly impact our financial condition or results of operations.  Reference is also made to the caption “Forward-Looking Statements” at the forepart of this Quarterly Report, which information is incorporated herein by reference.


Plan of Operations


We are engaged in the business of purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” These life insurance interests are anticipated to be held to maturity. Our plan of operation for the next 12 months is to continue the acquisition of these life insurance interests whereby we will acquire the interests in life insurance policies at a discount to their face value for investment purposes. We began purchasing the net insurance benefits in life insurance policies (“NIBs”) during our fiscal year ended March 31, 2013. This is not a market sector without competition, and at present, we are a minor competitor. We will need substantial additional funds to effectively compete in this industry, and no assurance can be given that we will be able to adequately fund our current and intended operations, whether through revenues generated from our current interest in the Qualified NIBs or through debt or equity financing. We may be required to expend not less than approximately $95.1 million on premiums, interest and servicing costs over the next five years to protect our interest in our NIBs, though we have no legal responsibility or adequate funds for these payments. These payments are currently being made through an unrelated senior lending facility.


We currently estimate proceeds of approximately $96.5 million on the NIBs owned as of June 30, 2015, and acquired from PCH Financial S.a.r.l., a société à responsabilité limitée incorporated and existing under the laws of the Grand Duchy of Luxembourg (“PCH”), Del Mar Financial S.a.r.l., a société à responsabilité limitée incorporated and existing under the laws of the Grand Duchy of Luxembourg (“Del Mar”) and HFII Assets Solutions, LLC, a Delaware limited liability company (“HFII”). This amount is based on the estimated proceeds from polices of approximately $341.2 million in face value, which includes estimated return of premiums; less the Senior Loans debt or MRI repayments outstanding of approximately $78.9 million, expected premium payments of approximately $100.3 million over the life expectancies and estimated expenses and interest of approximately $65.5 million over the term of the Senior Loans.


We use an estimation methodology to project cash flows and returns as presented. The estimation model required many assumptions, including, but not limited to the following: (i) an assumption that the distinct number of lives in our portfolio would exhibit similar experience to a statistically diverse portfolio based upon which the mortality tables have been created; (ii) an assumption that the life expectancies (the “LE” or “LE’s”) provided by LE providers represent the actuarial mean of the life expectancies of the insureds in our portfolio, (iii) the weighted average of the LEs provided by the LE providers represents an appropriate method for adjusting for discrepancies in the LE’s; (iv) life expectancy tables and projections are accurate; (v) the minimum premiums calculated based on the in-force illustrations provided by life insurance carriers are accurate and will not change over the course of the lifetime of our portfolio; and the Senior Lender fees, MRI fees, and insurance, servicing and custodial fees do not change materially over time. While this method of modeling cash flows is helpful in providing a theoretical expectation of potential returns that might be produced from our NIBs portfolio, actual cash flows and returns inevitably will be different (possibly materially) due to the fact that predicting the exact date of death of any individual is virtually impossible. The provision of a theoretical cash flow model is by no means any guarantee of any results. The actual performance of these NIB interests (as well as our future expectations as to what such performance might be) may differ substantially from our expectations, especially if any of the assumptions change or differ from our initial assumptions. These portfolios currently contain only 104 fractionalized policies on 60



14




individual insureds, though insurance rating agencies have stated that at least 1,000 lives are required to achieve actuarial stability. Many risk factors beyond these assumptions may result in our expectations being incorrect; therefore, no assurance can be given that these estimated results will occur.


We advanced payments to purchase future additional life settlement products during the quarter ended June 30, 2015, and if these life settlement products become “Qualified NIBs” as defined in the acquisition documents, we will also utilize the estimation methodology to estimate what our proceeds from these “Qualified NIBs” may be, all subject to the same assumptions, qualifications and risks referenced above.


Results of Operations


Income Recognition


Interest income on investment in NIBs represents the excess of all cash flows attributable to the investment in net insurance benefits greater than the initial investment over the life of each pool of net insurance benefits using the effective yield method.  Changes in the estimate of expected cash flows from investments in NIBs are adjusted prospectively.     


Interest income on investment in NIBs totaled $824,030 and $563,498 for the three months ended June 30, 2015, and 2014, respectively.  The increase is primarily due to the acquisition of additional NIBs in March 2015.


General & Administrative Expenses


General and administrative expenses totaled $595,954 and $616,366 during the three months ended June 30, 2015, and 2014, respectively.  A significant portion of these expenses were professional fees, payroll and travel expenses.


Other Income and Expenses


Other income and expenses primarily consist of interest on the note payable related-party and convertible debenture, as well as interest income. During the three months ended June 30, 2015, and 2014, interest expense has accrued in the amount of $39,202 and $16,141, respectively.  


Income Taxes


During the three months ended June 30, 2015, and 2014, we had no taxable income.


Liquidity and Capital Resources


From our inception on January 31, 2013, through the three months ended June 30, 2015, we incurred cumulative net losses of $263,952.  Management has expressed its belief that we need to raise approximately $40 million to $50 million in additional funds through equity or debt financing to continue our business model and to effectively compete in the life settlement industry during fiscal 2016 and beyond.  We raised $11,942,500 (gross) in our private placement that commenced in April 2013. Our monthly expenses are between approximately $140,000 and $290,000, which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and estimated legal and accounting expenses.  We believe we will have adequate cash resources for our estimated monthly expenses through August 31, 2016, excluding any other acquisitions of additional NIBs and other life settlement products.  


We held cash assets at June 30, 2015, and 2014, of $21,951 and $336,370, respectively.  We have only common stock as our capital resource. We will be reliant upon stockholder loans or private placements of equity or debt to fund any future operations. Although management is actively pursuing opportunities to raise additional equity and debt capital, we have secured no sources of loans, and there is no assurance that we will be able to raise any required debt or equity financing. We do not anticipate having adequate revenues from operations for three to four years, and until a revenue stream has been established, we will require debt or equity funding to fund our current and intended business. If management is unsuccessful in these efforts, discontinuance of operations is a possibility.


For the three months ended June 30, 2015, and 2014, we recorded net cash used in operating activities of $639,419 and $1,018,720, respectively. We used cash of $237,647 and $553,557 on advance for investments in NIBs under the Del Mar ATA.  



15





During March 2015, we agreed to pay cash, issue common stock and forgive a note receivable in exchange for relief of a $1,493,254 note payable (explained in Debt, below.  Also see Note 6 in the Footnotes to the Financials) and the receipt of NIBs.  The net consideration given for the relief of note payable and receipt of NIBs totaled $1,493,254 and $7,846,746, respectively, for a total of $9,340,000 (of which $150,000 is cash, $150,000 is forgiveness of a note receivable and $9,040,000 is common stock consideration).  Of the 1,130,000 common shares to be issued, 187,500 shares contain a redemption feature that requires the Company to buy back the shares for $8 per share ($1,500,000 in total) at the option of the holder.  The 1,130,000 common shares, including the 187,500 shares containing a redemption feature, were issued on June 9, 2015.  


Net cash provided by financing activities totaled $325,000 and $100,000 for the three months ended June 30, 2015, and 2014, respectively.  The increase in cash from financing activities was the result of drawing $700,000 on the an 8% Convertible Debenture dated June 2, 2015, as well as borrowing $375,000 from a Related Party, which amounts were offset by a $750,000 payment made on the exercise of the redemption right on 93,750 common shares.


Under our current business plan, we purchase NIBs only when they fit our model and our cash flows are sufficient to fund those purchases (with exception of the Del Mar ATA wherein we committed to purchase a certain number of Qualified NIBs as Del Mar made them available).  We expect to finance our NIBs purchases, as well as our operating working capital requirements, with proceeds from planned public and/or private offerings of our securities and debt financing. There can be no assurance that we will be successful in the anticipated equity and debt offerings or that we will be successful in raising additional capital in the future on terms acceptable to us, or at all.


If we are unable to raise sufficient capital through the planned securities and debt offerings or other alternative sources of financing, management will curtail NIB purchases.  We believe that we will be able to fund our operating working capital requirements with existing Lines-of-Credit and 8% Convertible Debentures Agreements, which totaled $6,245,000, of which $3,480,000 is available at July 31, 2015.


The accompanying financial statements have been prepared on a going concern basis under which we are expected to be able to realize our assets and satisfy our liabilities in the normal course of business. To continue as a going concern beyond the period ending August 31, 2016, and in order to continue to acquire life insurance policies and residual interests in or financial products tied to life insurance policies we will need to complete the planned securities and debt offerings or obtain alternative sources of financing. Absent additional financing, we will not have the resources to execute our business plan.


Debt


At June 30, 2015, we owed $2,625,444, including accrued interest, for long-term obligations.  On June 9, 2015, we converted a note payable and accrued interest to equity through the issuance of the 187,500 shares of common stock containing the redemption feature (as explained in Liquidity and Capital Resources, above). At June 30, 2015, we also held notes payable-related parties of $1,875,000, excluding accrued interest. We may borrow money in the future to finance our operations. Any such borrowing will increase the risk of loss to the debt holder in the event we are unsuccessful in repaying such loans.


Critical Accounting Policies and Estimates


The preparation of our financial statements requires that we make estimates and judgments. We base these on historical experience and on other assumptions that we believe to be reasonable.


Off-Balance Sheet Arrangements


We have no off-balance sheet arrangements.


Item 3.  Quantitative and Qualitative Disclosures about Market Risk.


Not required.




16




Item 4.  Controls and Procedures.


Evaluation of Disclosure Controls and Procedures


Our management, with the participation of our principal executive and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. Based on that evaluation, our President, who is also deemed to be our principal executive officer and our acting Chief Financial Officer (“CFO”), concluded that our disclosure controls and procedures as of the end of the period covered by the Quarterly Report were not effective and that the information required to be disclosed by us in reports filed under the Exchange Act is not (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our President and our acting CFO, as appropriate to allow timely decisions regarding disclosure.  A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.


We are in a continued process of adopting specific internal control mechanisms with our Board of Directors’ and our executive officers’ collaboration to ensure effectiveness as we grow our business.  We appointed a Chief Operating Officer (“COO”) in October, 2013, to assist us in adopting new measures to improve upon our internal controls. Future controls, among other things, will include more checks and balances and communication strategies between management and all members of the Board of Directors to ensure efficient and effective oversight over company activities as well as more stringent accounting policies to track and update our financial reporting and disclosure of information.  During 2014, we hired additional personnel and advisors, including a certified public accountant, to assist us with our internal control mechanisms.


 

Changes in Internal Control over Financial Reporting


With the exception of the matters discussed by us regarding our future controls to resolve our the present weaknesses in our controls and procedures, as discussed in the preceding section, there have been no changes in internal control over financial reporting.


PART II - OTHER INFORMATION


Item 1. Legal Proceedings.


We are not party to any material legal proceedings.


Item 1A.  Risk Factors.


Not required; however, for information about risk factors affecting us, our business and our common stock, see our 10-K Annual Report for the fiscal year ended March 31, 2015, and filed with the SEC on June 15, 2015, on pages 25 though 39 thereof, which is referenced in Part II, Item 6, below.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.


Sales of Unregistered Securities


On June 2, 2015, we entered into an 8% Convertible Debenture Agreement that allows us to borrow of up to $3,000,000 through September 30, 2016.  See Note (7) of our accompanying financial statements to this Quarterly Report, above.


The sale of the 8% Convertible Debenture underlying this 8% Convertible Debenture Agreement was exempt from the registration provisions of the Securities Act under Section 4(a)(2) thereof.  The purchaser was an “accredited investor” as that term is defined in Rule 501 of SEC Regulation D, and such purchaser had prior access to all of our filings made with the SEC under the Exchange Act.




17




Purchases of Equity Securities by Us or our Affiliates


There were no purchases by us or any affiliated persons of any shares of our equity securities during the quarter ended June 30, 2015.


Item 3. Defaults upon Senior Securities.


None; not applicable.


Item 4. Mine Safety Disclosures.


None; not applicable.


Item 5. Other Information.


(i)

On June 7, 2013, we entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar that involved the purchase of certain life settlement assets consisting of 100% of the legal and net beneficial ownership interest in a portfolio of life insurance policies or NIBs, among other assets that are consideration and collateral for certain cash advances and expense payments made by us. The original end result of the Del Mar ATA and the advance was not to purchase the NIBs provided as collateral, but instead to provide sufficient capital to Del Mar for the conversion of a portion of the NIBs and other potential NIBs into “Qualified NIBs.”  The original due date for the conversion was December 31, 2013, which date has subsequently been extended several times, with the most recent extension being to August 31, 2015.  The conversion can be accepted by us upon receipt of a combined face amount of $400,000,000 of “Qualified NIBs,” meaning that the NIBs would have premium financing secured for up to five years; that any grouping of NIBs would have not less than 10 policies; that the average age of the insureds under the life insurance policies would be approximately 81 years; and that the NIBs would have mortality re-insurance coverage. All remaining NIBs that are not converted to “Qualified NIBs” and all other assets that were  conveyed to us under the Del Mar ATA as collateral were to assure delivery of the Qualified NIBs by Del Mar and are to be re-conveyed to Del Mar conditional upon receipt of combined Qualified NIBs having a face amount equal to $400,000,000.  A complete description of the Del Mar ATA and the Europa Agreement, both as amended, is contained in our 8-KA-5 Current Report date June 7, 2014, which was filed with the SEC on July 10, 2014.  See Part II, Item 6 below.


During January 2014, we completed the closing of Qualified NIBs with associated death benefits of $90.6 million for $5,436,000. These Qualified NIBs are part of the $400,000,000 Qualified NIBs commitment under the Del Mar ATA.


During December 2014, Del Mar refunded $904,274 advanced by us because of Del Mar’s delay in delivering the remaining portion of the $400,000,000 Qualified NIBs commitment.  The refund was recorded as a reduction of Advance for Investment in Net Insurance Benefits in our condensed consolidated financial statements.


During June, 2015, we finalized an amendment to the Del Mar ATA and the related “Europa Agreement” (as defined below) to extend the deadline for delivery of the balance of the Qualified NIBs due until August 31, 2015.  The extension was intended to give the Company time to work towards a settlement agreement with Del Mar, as it appears unlikely that Del Mar will be able to fulfill its obligation to deliver the remaining $309,400,000 in Qualified NIBs. During this extension period, management will work toward a dissolution and resolution of the Del Mar ATA.


At June 30, 2015, we held collateral against the cash advances and expense payments made by us to Del Mar, which collateral includes NIBs associated with life settlement policies with a face value that originally totaled $94,000,000. During June 2015, one of the life settlement policies matured for $10,000,000, lowering the remaining face value of life settlement policies to $84,000,000 at June 30, 2015. The premiums and expenses related to the maintenance of these life insurance policies are financed by a loan from a Senior Lender. 


In the likely event Del Mar is unable to provide the Qualified NIBs by the extended due date of August 31, 2015, we will have the option of selling or retaining the collateral up to a liquidated damages settlement payment equal to 100% of any cash payments made under the Del Mar ATA. If the full balance of Qualified NIBs is provided by Del Mar, we will have paid $20,000,000 of consideration, $8,000,000 of which would be in cash and the remaining $12,000,000 in promissory notes. Promissory notes may be issued, pro rata, as Qualified NIBs are received. The



18




promissory notes have a two year term from the effective date and bear an interest rate of 4.0% per annum. Total interest and principal amounts are due upon maturity.


As part of the Del Mar ATA, we entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (respectively, the “Europa Agreement” and “Europa”). We are required to pay a structuring fee of 1% of the face amount of the life insurance policies underlying all NIBs introduced by Europa and acquired by us, payable as follows: 50% of the fee on the delivery of the NIBs; and the remaining 50% being payable on the conversion of the NIBs to Qualified NIBs. The total restructuring fee will be up to $4,000,000.  In the event that any cash consideration paid by us under the Del Mar ATA exceeds the defined $8,000,000 cash threshold, the amount payable under the Europa Agreement will be reduced on a dollar for dollar basis for any such overage. The total purchase price will not exceed $24,000,000 under the Del Mar ATA, which is comprised of $12,000,000 in cash consideration and $12,000,000 in promissory notes.


On October 29, 2013, we and Europa, with the agreement of Del Mar, amended the Europa Agreement and the Del Mar ATA to acknowledge that the total up-front cash payment due from us under the Del Mar ATA and Europa Agreement shall not exceed $12,000,000; that we would receive a credit on a dollar for dollar basis of the cash payment and all costs and expenses paid under the Del Mar ATA over $8,000,000, against all fees due Europa under the Europa Agreement or the Del Mar ATA. In the event the Qualified NIBs delivered are less than $300,000,000 in face value under the Del Mar ATA Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA   and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by the Company, multiplied by two; and if at least $300,000,000 in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within 90 days.


During the fiscal year ended March 31, 2015, a substantial portion of the assets held by us as collateral for performance under the Del Mar ATA and the Europa Agreement was released.  It was our management’s belief that the assets released were too highly leveraged in a manner that would require excessive amounts of additional equity, that when evaluated extensively, it was determined that reaching the targeted rate of return for us would be difficult.  Some of the key reasons for the release of collateral assets include, but are not limited to, the following:


-

NIBs portfolio debt levels were too highly leveraged, thus creating a debt level unacceptable to management.

-

Changes in life expectancies within the portfolios required additional equity on some policies to make the Senior Loans required more acceptable for the lending institution, and we were unwilling to commit the additional equity.

-

Our evaluation process exposed some of the assets as less than ideal for our desired rate of return, thus making a total portfolio unacceptable.


We continue to hold assets acquired under the Del Mar ATA that are being evaluated and processed to fit our Qualified NIBs criteria.  As mentioned above, they will need to fit our processes and structure without compromising our expected rates of return.  We do believe that if we are required to exercise our rights with regards to seeking the liquidated damages settlement by foreclosing on the collateral, while retaining the $90,600,000 in Qualified NIBs that have already been received by us under the Del Mar ATA, that the collateral we now hold has sufficient value to recover such damages.


Also on October 29, 2013, we entered into an Exclusivity Agreement with the consultant to Europa under the Europa Agreement under which the Company advanced $25,000 to such consultant for services related to the purchase of Qualified NIBs associated with the $400,000,000 in life insurance policies due under the Del Mar ATA.


(ii)

Certain founding shareholders of the Company owning approximately 32,727,000 shares of our common stock who executed and delivered Lock-Up/Leak-Out Agreements restricting the sale of their respective shares of common stock of the Company until on or about October 5, 2014, a date which was 18 months from the filing of our 8-K Current Report dated March 29, 2013, and filed with the SEC on April 5, 2013, regarding our acquisition by merger of ANEW LIFE, INC., a Utah corporation that became our wholly-owned subsidiary following such merger (“ANEW LIFE”), have executed and delivered Agreements that have extended the Lock-Up Period under these Lock-Up/Leak-Out Agreements for an additional year, to on or about October 5, 2015, and the Leak-Out Period in their initial Lock-Up/Leak-Out Agreements will now commence on the expiration of the new Lock-Up Period, or October 5, 2015.  These persons received their respective shares of common stock of the Company on the organization of ANEW LIFE and its subsequent merger into the Company on a share for share basis.  Certain other



19




smaller founding shareholders or their transferees who collectively own approximately 225,000 shares of our common stock, each of whom owned less than 100,000 shares of our common stock, have also agreed to extend their respective Lock-Up Periods to October 5, 2015.  See Part II, Item 6, below.


(iii)

On December 5, 2014, we executed a binding Letter of Intent (“LOI”) to memorialize the intent of HFII to enter into an Asset Purchase Agreement with us involving the issuance of 1,130,000 shares of our common stock in exchange for two portfolios of Qualified NIBs then held by HFII in Hyperion Funds II plc. The life settlement policies underlying these Qualified NIBs have a combined face value at maturity of approximately $124,375,000.  In addition, the LOI states that the collateral will be released relating to the $2,999,000 in assets contained in the Amended and Restated Promissory Note held by us that was initially executed and delivered to Del Mar on November 5, 2013 (See Note 6 of our condensed consolidated financial statements above).  Also, the LOI outlines that up to 187,500 shares of our common stock anticipated to be issued in the proposed transaction will have a put right held by HFII that will require us to buy back the shares at $8 per share.   We executed and delivered the HFII Asset Transfer Agreement on March 2, 2015, and as amended on March 31, 2015, under which we agreed to acquire, and HFII agreed to sell, certain NIBs and exchanged certain debt for equity as outlined in the LOI of December 5, 2014, referenced above, in consideration of our agreement to issue HFII 1,130,000 shares of our common stock, with such shares being subject to a 12 month Lock-Up Agreement and with 187,500 of the shares containing a redemption feature (the First and Second Put Options) that may require the Company to buy back the shares for $8 per share on the option of the holder.  Under the HFII Asset Transfer Agreement, we granted HFII a Put Option to put to us 187,500 of our shares that we agreed to issue to HFII, at a purchase price of $8.00 per share or an aggregate total of $1,500,000, in two puts: (i) 93,750 shares for $8.00 per share or a total of $750,000 (the “First Put Option”), which amount has been paid by us ($375,000 on April 2, 2015, and $375,000 on June 9, 2015) and (ii) 93,750 shares on October 31, 2015, for $8.00 per share or a total of $750,000 (the “Second Put Option”), which is currently in negotiation to be extended to September 30, 2016.  If the holder elects to exercise the second redemption agreement relating to the remaining 93,750 shares and if we do not have the liquidity to pay the Second Put Option, the Clawback Rights of HFII provide that the Asset Purchase Agreement shall be terminated; we shall return all of HFII’s assets; HFII shall repay the Consideration and any other costs and expenses paid by us in connection with its assets (including, but not limited to any Put Option payments made); and HFII shall offset amounts owed by us under the Amended and Restated Promissory Note by such Consideration any Put Option payments made; and any other costs and expenses paid by us in connection with HFII’s assets, which additional costs and expenses shall be agreed upon by us and HFII in one or more separate writings. We have a 45 day Cure Period on the Second Put Option.  A complete description of the HFII LOI and Asset Transfer Agreement, as amended, is contained in our 8-KA-2 Current Report dated December 5, 2014, which was filed with the SEC on April 7, 2015.  See Part II, Item 6, below.


(iv)

During July, 2015, a group of persons located in the United States (the “Purchasers”) acquired the entities that owned all of the portfolios of life insurance contracts underlying our NIBs.  We were supportive of the purchase because we believe this ownership change will result in a reduction of costs and expenses associated with ownership of the NIBs, which should increase their intrinsic value.  The Purchasers have also agreed to amend the NIBs agreements to provide greater disclosure to us and limit permitted expenses to be paid prior to payments to the NIBs holders, pending certain regulatory and tax approvals.  In connection with this purchase, the Purchasers and the respective owners of these portfolios entered into a Settlement Agreement releasing such owners and their managers from liability related to their ownership and management of the entities that owned the respective portfolios of life insurance contracts.  The Purchasers further required releases from us and the payment of certain accrued expenses.  Accordingly, effective as of July 17, 2015, the Purchasers acquired all of the ownership interests in the entities that owned all of the portfolios of life insurance contracts underlying the Company’s NIBs from their prior owners and executed a Settlement Agreement with such owners and the Company in relation to these matters.  The NIBs Amendments are in process, and we believe the NIBs amendments will be in effect within the next six months.  In addition, we and Purchasers agreed to indemnify the prior owners of such portfolios against future claims in connection with the issuance of the NIBs or their ownership by, or management of, the entities sold, based on actions that occurred prior to this sale to the Purchasers.  Management is presently not aware of the existence of any such claims.  Neither the purchase of these entities nor the Settlement Agreement resulted in any material change in our NIBs ownership interest.


(v)

On July 22, 2015, we entered into a Line-of-Credit agreement with a related party, stockholder and Board member that allows for borrowings of up to $1,115,000.  The note incurs interest at 7.5 percent, allows for origination fees, has a due date of September 30, 2016, or at the immediate time when the anticipated raise in equity funds is successful, and is collateralized by Advance for Investment in NIBs.  During the three months ended June



20




30, 2015, we borrowed $375,000, and subsequent to June 30, 2015, we drew an additional $190,000 on the Line-of-Credit, for a total of $565,000 drawn on the Line-of-Credit as of the date of this filing.


Item 6. Exhibits.


Exhibit No.                          Identification of Exhibit


Exhibit Number

Description

 

 

10.1

Form of Lock-Up/Leak-Out Agreement*

10.2

Form of Extension Agreement to Lock-Up/Leak-Out Agreement**

10.3

HFII Asset Transfer Agreement

10.4

Amendment No. 1 to HFII Asset Transfer Agreement

10.5

Debenture Agreement dated June 2, 2015

10.6

8% Convertible Debenture

10.7

Line-of-Credit Agreement

31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act provided by Randall F. Pearson, President and Director.

31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act provided by Randall F. Pearson, acting CFO.

32

Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 proved by Randall F. Pearson, President and acting CFO.

 

 

101.INS

XBRL Instance Document

101.PRE.

XBRL Taxonomy Extension Presentation Linkbase

101.LAB

XBRL Taxonomy Extension Label Linkbase

101.DEF

XBRL Taxonomy Extension Definition Linkbase

101.CAL

XBRL Taxonomy Extension Calculation Linkbase

101.SCH

XBRL Taxonomy Extension Schema


*Filed as Exhibit 10.7 to our Current Report on Form 8-K dated March 29, 2013, and filed with the SEC on April 5, 2013.

**Filed as Exhibit 10.2 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, and filed with the SEC on November 11, 2014.


Documents Incorporated by Reference


8-KA-2 Current Report dated December 5, 2014, which was filed with the SEC on April 7, 2015, regarding the amendment to the Asset Transfer Agreement with HFII.


8-KA-1 Current Report dated December 5, 2014, which was filed with the SEC on March 6, 2015, regarding our Asset Transfer Agreement with HFII.


8-K Current Report dated December 5, 2014, and filed with the SEC on December 8, 2014, regarding our LOI with HFII.


8-K Current Report dated October 21, 2013, which was filed on October 24, 2013, regarding the employment of a COO.


10-K Annual Report for the fiscal year ended March 31, 2015, and filed with the SEC on June 15, 2015.


8-K Current Report dated June 7, 2013, as amended, and filed with the SEC on June 20, 2013, November 14, 2013, May 5, 2014, May 27, 2014 and July 10, 2014, regarding the Del Mar ATA.


8-K Current Report dated March 29, 2013, which was filed with the SEC on April 5, 2013, along with our 8-KA Current Reports of the same date, which were respectively filed with the SEC on May 24, 2013, July 12, 2013, September 12, 2013, and November 27, 2013, regarding the PCH Transfer Agreement.



21




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized


SUNDANCE STRATEGIES, INC.


Date:

August 10, 2015

  

By:

/s/Randall F. Pearson

  

  

  

  

Randall F. Pearson, President, CEO and Acting CFO




22




 





March 2, 2015







HFII Assets Solutions, LLC

as Seller and

Sundance  Strategies, Inc. as Buyer
















Asset Purchase Agreement



1



THIS ASSET PURCHASE AGREEMENT (the "Agreement") is made effective as of the 2nd day of March, 2015 (the "Effective Date"):


BETWEEN


HFII  Assets  Solutions,  LLC,   a  Delaware  limited  liability  company,  having  its registered office at 1209 Orange Street, Wilmington, DE 19801 (the "Seller'');


and


Sundance Strategies, Inc., a corporation incorporated under the laws of the State of Utah, USA, having its registered  office at 4626 North 300 West, Suite 365, Provo, Utah 84604, USA (the "Buyer'');


each a "Party" and together the "Parties" to  this Agreement.


WHEREAS


(A)

The Seller holds an aggregate  of 10,821,174 participating  debt certificates with a nominal  value  of  one  US  dollar  (US  $1.00}  issued  by  the  companies  listed on Exhibit A (the "Existing PDCs"), representing a total issue of Existing PDCs having an aggregate par value of US $10,821,174.00 as set forth in Exhibit A; and


(B)

Seller holds that certain Promissory Note issued by Buyer in connection  with that certain NIB Transfer  Agreement dated March 11, 2013 (the "Sundance Note"), a copy of which is attached as Exhibit B ; and


(C)

The Existing PDCs represent the net insurance benefits ("NIBs") from a portfolio of life settlement policies as set forth in Exhibit C; and


(D)

Buyer  and  Seller  entered  into  a  binding  letter  of  intent  on  December  5, 2014, whereby the Buyer agreed to buy, and the Seller agreed to sell, the Existing PDCs and Sundance Note subject to certain contingencies (the "LOI"), a copy of which is attached as Exhibit D ; and


(E)

Buyer and Seller have agreed to waive any outstanding  contingencies  in the LOI and hereby complete the transfer of the Existing PDCs and Sundance Note to Buyer according to the terms and provisions set forth below.


THE PARTIES HEREBY AGREE AS FOLLOWS:


1.

Construction


1.1

In this Agreement, any reference to any agreement  (howsoever named) is to such agreement as it may be amended, supplemented or extended from time to time, whether before or after the date hereof.



2




1.2

Clause headings are for ease of reference only.


1.3

For  purposes  of  this  Agreement  and  any  future  communications  between the Parties,  the term "PDCs" and "NIBs" shall be considered  interchangeable  and all Parties hereby acknowledge and agree to their interchangeability.


2.

Transfers


The Seller agrees to sell and transfer to the Buyer, which the Buyer accepts, the Existing PDCs and the Sundance Note for the Consideration, defined below.


3.

Consideration & Payment


The total consideration for the transfer of the Existing PDCs and the Sundance Note shall be One Million,  One Hundred  Thirty  Thousand  (1,130,000)  shares  of newly issued common  shares of Buyer (the "Consideration") (the "Sundance Shares"). The Consideration is subject to the following rights and conditions:


3.1

Lock Up I Leak Out.   Except as permitted  in connection  with Seller's  Put Option (defined below), or with the written consent of Buyer, Seller shall be prohibited from selling, hypothecating or otherwise dividing or assigning the Sundance Shares for a period of 12 months  from the date of issuance  and such restrictions shall be set forth on the stock certificates evidencing the Sundance Shares.


3.2

Put Option.  Seller shall have the option to sell and, if Seller elects to exercise such option, Buyer shall be obligated to purchase, up to an aggregate of 187,500 of the Sundance Shares from Seller at a price of $8.00 per share ($1,500,000) (the "Put Option") in accordance with the following:


a)

Exercise Dates:


i.

Seller  can  elect  to  exercise  its  Put  Option  to  sell  up  to  93,750 of  the Sundance Shares back to Purchaser on March 2, 2015, for an aggregate exercise price of $750,000 (the "First Exercise Date").


ii.

Seller  can  elect  to  exercise  its  Put  Option  to  sell  up  to  93,750 of  the Sundance   Shares   back  to   Purchaser  on  October  31, 2015,  for  an aggregate exercise price of $750,000 (the "Second Exercise Date").


b)

Expiration  of  Put  Option.    Each  of  the  Put  Options  shall  expire  on  their respective exercise dates if not exercised.



3




c)

Exercise Notice.   Seller may make its election to exercise the Put Option by providing written notice to Buyer on the applicable exercise date and returning the related Sundance Shares, endorsed to Buyer.


d)

Payment of Option Price.    Buyer shall pay the exercise price within two (2) days of its receipt of Seller's exercise notice and its receipt of the related Sundance Shares.


e)

Clawback  of Existing PDCs.      If Buyer fails to pay the exercise price within two (2) days of its receipt of an exercise notice and its receipt of the related Sundance Shares, plus any cure period, then Seller shall have the right to demand the return of its assets (the "Ciawback Rights"), as follows:


i.

If Buyer fails to pay the exercise price related to the First Exercise Date and the Buyer and Seller fail to extend the payment date, this Agreement shall be terminated and Buyer shall return all of Seller's assets and Seller shall repay the Consideration and any other costs and expenses paid by Buyer in connection with Seller's assets.   In the case of termination, Seller shall offset amounts owed by Buyer under   the   Sundance   Note   by  the Consideration   and  any  other  costs  and  expenses   paid  by Buyer in connection with Seller's assets, which shall be agreed upon by Buyer and Seller in one or more separate writings.


ii.

If Buyer fails to pay the exercise price related to the Second Exercise Date and the Buyer and Seller fail to extend the payment date, this Agreement shall be terminated and Buyer shall return all of Seller's assets and Seller shall repay the Consideration (including any proceeds from the exercise by Seller of its Put Option) and any other costs and expenses paid by Buyer in connection  with Seller's assets.    In the case  of termination,  Seller shall offset amounts owed by Buyer under the Sundance Note by any proceeds from the exercise by Seller of its Put Option and by the Consideration and any other costs and expenses  paid by Buyer in connection  with Seller's assets, which shall be agreed upon by Buyer and Seller in one or more separate writings.


f)

Cure Period.  In the event Buyer fails to timely pay the exercise price to Seller in connection with a properly exercised  Put Option due to a lack of adequate liquidity,  as determined  in the  Buyer's  sole  discretion,  Buyer shall have  (i) twenty-nine (29) calendar days from the receipt of an exercise notice related to the First Exercise Date and (ii) forty-five (45) calendar days from the receipt of an exercise notice related to the



4



Second Exercise Date, to pay the related exercise price prior to Seller exercising any Clawback Rights.


4.

Transfers


4.1

Use of Proceeds of Transferred  Assets.   Pending the expiration of the Put Option and any Clawback Rights, Buyer shall own and control the Existing PDCs and Sundance  Note.    Buyer  hereby  agrees  to  maintain  the  Existing  PDCs  in  good standing (including the payment of all costs and expenses related to the assets underlying the Existing PDCs) and to hold such Existing PDCs, free from any encumbrances,  until the expiration of such Put Option and Clawback Rights.


5.

Initial Closing Conditions


5.1

NIB Registration.  The Seller and Buyer shall take such steps necessary to register the  Buyer  as  holder  of  the  Existing  PDCs  in  its  register  of  NIBs. The  Parties expressly grant power to the manager of the NIB issuer, acting individually and with full power of substitution, to amend and execute the above register for and on behalf of the  NIB  issuer  and the Buyer and to  do all such acts and things  as may be ancillary thereto and/or necessary and/or useful and/or desirable in the sole opinion of such manager in connection with or for the purpose of giving full effect to this Agreement.   Upon amendment and execution of the above register, the manager of the NIB issuer shall cause to be delivered to Buyer via email (to be followed by a hard copy via courier) a copy of such amended and executed register and confirm to Buyer via email (to be followed by a hard copy via courier) that the Buyer has been registered as the holder of the NIBs in its register of NIBs and is entitled to all rights and privileges of such ownership, including the right to transfer or convey such NIBs without  further consent  of  any  person,  except  only  as  may  be  limited  by  this Agreement.


5.2

Sundance Note Transfer.  The Seller shall deliver to the Buyer, the Sundance Note, duly endorsed over to Buyer and listed on a Bill of Sale in the form attached hereto in Exhibit E.


6.

Representations and Warranties


6.1

The Seller, and any of its affiliates or subsidiaries having any interest in the assets being  transferred  hereunder,  represents  and  warrants  to  the  Buyer  as  of  the Effective Date as follows:


(a)

The Seller is a validly organized  and existing limited liability company  under the  laws  of  the  State  of  Delaware,  and  it  has  the  corporate  power  and authority to enter into this Agreement and to perform its 

 obligations hereunder;




5



(b)

The execution and the performance of this Agreement by the Seller have been duly   authorized   by   its  managers   and/or   any   and   all other necessary management  body(ies)  of the Seller and no further corporate action on the part  of  the  Seller  is  necessary   to  authorize  this Agreement  and/or  its performance;


(c)

This Agreement has been duly executed by the Seller, and this Agreement constitutes the valid and binding agreement of the Seller, enforceable against it in accordance with the terms hereof;


(d)

Each issuer of the Existing PDCs (each a "Company"), set forth on Exhibit A, is  a private  limited  liability  company   (societe  a responsabilite  limitee) duly incorporated and validly existing under the laws of Luxembourg;


(e)

To the best of the Seller's knowledge,  the "centre of main interests" (as that term is used in the Council Regulation (EC) No 1346/2000 of 29 May 2000 on insolvency proceedings, the "Insolvency Regulation") of each Company is in Luxembourg, and each Company has no "establishment" (as that term is used in the Insolvency Regulation) outside Luxembourg;


(f)

In respect of this Agreement and the transactions contemplated by, referred to in or provided for by this Agreement, (i) it entered into this Agreement in good faith and for the purpose of carrying out its business, (ii) it entered into this Agreement on arms' length commercial term, and (iii) it entered into this Agreement without any intention to defraud or deprive of any legal benefit any other parties (such as third parties and in particular creditors) or to circumvent any applicable mandatory laws or regulations of any jurisdiction;


(g)

To the best of the Seller's knowledge, no action, petition, resolution or similar order for bankruptcy (faillite), voluntary or judicial winding-up (liquidation volontaire ou judiciaire), controlled management (gestion contralee), suspension  of  payment   (sursis  de  paiement), voluntary  arrangement  with creditors   (concordat  preventif de faillite) or similar proceedings  affecting the rights of creditors generally has been taken, lodged, passed or presented with regard to the Company and the Seller;


(h)

The Seller and each Company do not meet or threatens to meet the criteria for the opening of any proceedings referred to under the above paragraph;


(i)

The Seller is the sole beneficial  and legal owner  of the Existing PDCs and Sundance Note;







(J)

As of the Effective Date, the Existing PDCs are validly issued and fully paid up and represent in aggregate one hundred percent (100%) of the Existing PDCs issued by the Companies; and the Seller is not aware of any document related to the Existing PDCs that would preclude the Seller from consummating the transactions contemplated hereunder;


(k)

As of the Effective Date, the Seller shall own the Existing PDCs and Sundance Note free and clear of any lien, security interest, claim, option, pledge, charge, assignment, transfer and other encumbrances of any kind;


(I)

As of the Effective Date, each policy listed on Exhibit C is valid, in-force and in good-standing and has not lapsed nor is in any grace period.


(m)

This Agreement  does not violate any contractual  or other obligation binding upon it and each Company.


(n)

There are no proceedings or litigation at law, equity or otherwise pending or, to the knowledge  of the  Seller,  threatened  against  the  Seller,  or to which the Seller is otherwise  a  party  before  any  Governmental Authority, which,  if adversely  determined,  would  reasonably  be  expected  to  have a material adverse effect on the ability of the Seller to perform its obligations under this Agreement,  or to consummate  the  transactions contemplated hereby.  The Seller is not subject to any order of any Governmental Authority except to the extent the same would not reasonably be expected to have a material adverse effect on the ability of the Seller to perform its obligations under this Agreement or to consummate the transactions contemplated hereby.


(o)

The Seller: (i) has had access  to all reports and registration  statements and other information filed by the Buyer with the United States Securities and Exchange Commission (the "SEC") at www.sec.gov; is an "accredited investor" or "sophisticated investor" as those terms are defined in SEC general rules and regulations, and specifically in SEC Rules 501 and 506, each of its principals is also an "accredited investor" or "sophisticated investor"; is fully capable of evaluating the risks and merits of an investment in the Sundance Shares; understands that the Sundance Shares are "restricted securities" as defined in SEC Rule 144; and has had the opportunity, through its principals and legal counsel,  to  ask  questions  of and  receive  answers  from  the  directors  and executive officers of Buyer, to the Seller's satisfaction.


6.2

The Buyer hereby represents and warrants to the Seller as follows:







(a)

The  Buyer  is  a  corporation  duly  organized,  validly  existing  and  in good standing under the laws of its state of incorporation, and it has the corporate power and authority to enter into this Agreement and to perform its obligations hereunder;


(b)

The execution and the performance of this Agreement by the Buyer have been duly authorized by its managers and/or any and all other necessary management  body(ies) of the Buyer and no further corporate action on the part of the Buyer is necessary to authorize this Agreement and/or its performance;


(c)

This Agreement has been duly executed by the Buyer and this Agreement constitutes the valid and binding agreement of the Buyer, enforceable against it in accordance with the terms hereof;


(d)

In respect of this Agreement and the transactions contemplated by, referred to in or provided for by this Agreement, (i) it entered into this Agreement in good faith and for the purpose of carrying out its business, (ii) it entered into this Agreement on arms' length commercial terms and (iii) it entered into this Agreement without any intention to defraud or deprive of any legal benefit any other parties (such as third parties and in particular creditors) or to circumvent any applicable mandatory laws or regulations of any jurisdiction.


(e)

No action, petition, resolution or similar order for bankruptcy (faillite), voluntary or judicial winding-up (liquidation volontaire ou judiciaire) controlled management (gestion controlee), suspension of payment (sursis de paiement), voluntary arrangement with creditors (concordat preventif de faillite) or similar proceedings affecting the rights of creditors generally has been taken, lodged, passed or presented with regard to the Buyer; and


(f)

This Agreement does not violate any contractual  or other obligation binding upon it.


7.

Costs


Except as otherwise provided herein, each Party shall bear its own costs, fees and expenses incurred in the negotiation, execution and performance of this Agreement and any matter contemplated by it.


8.

Further Assurances


The Parties each agree to execute and deliver such additional instruments and other documents, and to take all such further actions, as may be reasonably necessary or appropriate  to  effectuate,  carry  out  and  comply  with  all  of  the terms  of  this Agreement and the transactions contemplated hereby.







9.

Relationship of Parties


Nothing  contained   herein   is  intended,   nor  shall   be  construed,   to  create  a partnership, joint venture or other similar association between or among any of the Parties hereto for any purpose.


10.

Waiver


The failure or delay of any Party hereto to enforce at any time any of the provisions of this Agreement shall in no way be construed as a waiver of any such provision, nor in any way to affect the validity or this Agreement or any part hereof or the right of such Party thereafter to enforce each and every such provision.   No waiver of any breach of or non-compliance  with this Agreement shall be held to be a waiver of any other or subsequent breach or non-compliance.   All remedies, either under this Agreement or by law or otherwise afforded, will be cumulative and not alternative.


11.

Entire Agreement


This  Agreement  constitutes  the  entire  and  sole  agreement  between  the Parties thereto on the provisions covered by it. This agreement may only be amended or modified  by  a  written  document   signed  by  the  Seller  and  the Buyer;  and  it supersedes the LOI.


12.

Amendments


No modification, amendment or waiver of, or with respect to, any provision of this Agreement, and all other agreements, instruments and documents delivered pursuant to this Agreement, shall be effective unless it shall be in writing and signed by each of the Parties.


13.

Severability


The unenforceability or nullity of any provision of this agreement shall not affect the validity or enforceability of any other provisions hereof.


14.

Governing Law, Jurisdiction and Waiver of Jury Trial


THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE  WITH,  THE  LAWS  OF  THE  STATE  OF  UTAH.    ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS AGREEMENT MAY BE BROUGHT  IN THE  COURTS  OF THE STATE  OF UTAH  OR OF THE UNITED STATES FOR THE CENTRAL DISTRICT OF UTAH, AND BY EXECUTION AND DELIVERY  OF THIS  AGREEMENT,  EACH  OF  THE PARTIES  HERETO CONSENTS, FOR ITSELF AND IN RESPECT OF ITS PROPERTY, TO THE EXCLUSIVE  JURISDICTION  OF  THOSE COURTS.  EACH  OF  THE  PARTIES HERETO  IRREVOCABLY  WAIVES  ANY OBJECTION,  INCLUDING  ANY OBJECTION TO THE LAYING OF VENUE






OR BASED ON THE GROUNDS OF FORUM NON CONVENIENS, OR ANY LEGAL PROCESS WITH RESPECT TO ITSELF  OR  ANY OF ITS PROPERTY, WHICH  IT MAY  NOW  OR HEREAFTER HAVE TO THE BRINGING OF ANY ACTION OR PROCEEDING IN SUCH JURISDICTION IN RESPECT OF THIS AGREEMENT OR ANY DOCUMENT RELATED HERETO. EACH OF THE PARTIES HERETO WAIVES PERSONAL SERVICE  OF  ANY  SUMMONS, COMPLAINT  OR  OTHER  PROCESS,  WHICH MAY  BE  MADE  BY  ANY OTHER  MEANS  PERMITTED  BY  UTAH  LAW.   ALL PARTIES HEREUNDER HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY  WAIVE ANY RIGHTS THEY MAY HAVE TO A TRIAL BY JURY IN  RESPECT  OF  ANY LITIGATION  BASED  HEREON,  OR  ARISING  OUT  OF, UNDER, OR IN CONNECTION WITH, THIS AGREEMENT, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS  (WHETHER ORAL OR WRITTEN) OR ACTIONS OF THE PARTIES IN CONNECTION HEREWITH OR THEREWITH. ALL PARTIES ACKNOWLEDGE AND AGREE THAT THEY HAVE RECEIVED FULL AND SIGNIFICANT  CONSIDERATION  FOR THIS PROVISION AND THAT THIS PROVISION IS A MATERIAL INDUCEMENT FOR ALL PARTIES TO ENTER INTO THIS AGREEMENT.


Notwithstanding  anything contained  herein  to the contrary, it is the Parties' intent that this Agreement and the Promissory Note shall be governed by, and construed in accordance with, the laws of the State of Utah, but the Pledge Agreement shall be governed by, and construed in accordance with, the laws of Luxembourg.


15.

Headings


The headings  herein  are for purposes  of reference  only and  shall not  otherwise affect the meaning or interpretation of any provision hereof.


16.

Counterparts


This Agreement may be executed by the parties in separate counterparts,  each of which when so executed shall be deemed to be an original and both of which when taken together shall constitute one and the same agreement.







IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed in counterparts as of the date first above written.



THE SELLER


HFII Assets Solutions, LLC





By:  Mark Niu

Title: President of Hyperion Capital, LLC

as Manager of HFII Assets Solutions, LLC



THE BUYER


[ASSETPURCHASEAGREEMENTWEX002.GIF]






Exhibit A



Schedule of Existing PDCs (NIBs)



Issue

Date


Company


Series


No. of

PDCs


Par Value

1/10/2013

Apollo Life Ventures Sari

-

2,022,500

2,022,500

1/15/2013

Apollo Life Ventures Sari

-

452,250

452,250

1/15/2013

Apollo Life Ventures Sari

1

1,128,044

1,128,044

1/10/2013

Jubilee Star Lux Sari

-

1,842,500

1,842,500

1/15/2013

Jubilee Star Lux Sari

-

452,250

452,250

1/15/2013

Jubilee Star Lux Sari

1

1,598,630

1,598,630

9/20/2012

HTF 3 US Life Ventures Sari

1

1,565,000

1,565,000

9/20/2012

HTF 4 US Life Ventures Sari

1

1,760,000

1,760,000


Total

 


10,821,174


$10,821,174






Exhibit B


Sundance Note






Exhibit C


Life Insurance Policies

Underlying Existing PDCs


Policy ID

Structure

Carrier

Death Benefit

BYJR796

HTF 3-4

Natl Western

2,500,000

FRR0759

HTF 3-4

Hancock

1,500,000

SAEZ777

HTF 3-4

West Coast

5,000,000

CHGE113

HTF 3-4

LBL

5,000,000

DAJ042U

HTF 3-4

Columbus

5,000,000

SCJ0458

HTF 3-4

Lincoln

7,000,000

CAMA813

HTF 3-4

AXA

5,000,000

TAMA166

HTF 3-4

SLD

4,000,000

KEGE662

HTF 3-4

Lincoln

2,400,000

KOS 715

HTF 3-4

AXA

5,000,000

QULU73U

HTF 3-4

Columbus

4,500,000

ALKI480

HTF 3-4

AXA

3,000,000

ROTH439

HTF 3-4

Hancock

2,000,000

COGI951

HTF 3-4

SLD

5,000,000

BOR0618

HTF 3-4

SLC

2,000,000

CHLL709

HTF 3-4

Prudential

5,000,000

CUWI510

Apollo I Jubilee

AXA

1,500,000

BAJ0839

Apollo I Jubilee

AXA

1,500,000

CODE678

Apollo I Jubilee

JP

7,000,000

FIHA557

Apollo I Jubilee

AXA

10,000,000

HOBU508

Apollo I Jubilee

Protective

1,500,000

NEED928

Apollo I Jubilee

Natl Western

2,000,000

RERI287

Apollo I Jubilee

Hartford

10,000,000

STMI968

Apollo I Jubilee

AXA

5,000,000

STMI315

Apollo I Jubilee

AXA

5,000,000

WODI680

Apollo I Jubilee

ReliaStar

3,000,000

ALD0130

Apollo I Jubilee

AXA

10,000,000

COR0121

Apollo I Jubilee

Hancock

3,000,000

CRJA0U

Apollo I Jubilee

Columbus

975,000

TOTAL

124,375,000







Exhibit D


Letter of Intent






Exhibit E


Bill of Sale


Bill of Sale - Sundance Note



BILL OF SALE AND ASSIGNMENT



BILL OF SALE AND ASSIGNMENT, dated as of this  

day of March, 2015 (this "Bill of Sale"), from HFII Asset Solutions, LLC (the "Seller"), to Sundance Strategies, Inc. (the "Buyer");


WITNESSETH:


WHEREAS, the undersigned entered into an Asset Purchase Agreement (the "Agreement"), dated as of March 2, 2015.  All capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Agreement; and


WHEREAS,   subject to and in accordance  with the terms and conditions of the Agreement, the  Seller  has  agreed  to  transfer  to  the  Buyer  the  Sundance  Note (the   "Transferred Property").


NOW, THEREFORE, in consideration of the payment by the Buyer to the Seller of the Consideration, and for other good and valuable consideration, the receipt and sufficiency of which  is  hereby  acknowledged,  the  Seller  by  these  presents  does hereby  sell,  convey, transfer and assign to the Buyer, its successors and assigns forever, all of the Seller's right, title and interest, legal and equitable, in and to the Transferred Property.


TO HAVE AND TO HOLD, unto the Buyer, its successors  and assigns, from and after the passage of title as aforesaid, FOREVER.


The  Transferred  Property  is  being  sold  to  the  Buyer  with  only  such representations  or warranties as expressly set forth in the Agreement, herein or in the accompanying  certificate of an authorized officer of the Seller.


The Seller shall be solely responsible for any and all transfer taxes and filing fees incurred by it in connection with this sale of Transferred Property by the Seller to the Buyer.


This instrument  shall be binding  upon, inure to the benefit  of, and be enforceable  by the Buyer and the Seller and their respective successors and assigns.


IN WITNESS WHEREOF, the Seller has caused this Bill of Sale to be executed by its duly authorized officer as of the date first above written.


HFII Assets Solutions



By: Title:








March 31, 2015







HFII Assets Solutions, LLC

as Seller and

Sundance Strategies,Inc.

as Buyer
















Amendment No.1 to

Asset Purchase Agreement



THIS AMENDMENT NO.1 TO ASSET PURCHASE AGREEMENT (the "Amendment") is made effective as of the 31st day of March, 2015 (the "Effective Date") amending that certain Asset Purchase Agreement (the "Agreement") dated the 26th day of February, 2015 between HFII Assets Solutions, LLC.(the "Seller") and Sundance Strategies,Inc., (the "Buyer"). All capitalized terms not defined herein shall have the meaning given to such terms in the "Agreement".


WHEREAS


(A)

Under the Agreement, the Seller sold the Existing PDCs and the Sundance Note to

Buyer.


(B)

Under the Agreement, the Seller was granted a Put Option which was exercised by

Seller on February 26, 2015.


(C)

Under the Put Option, Buyer was obligated to purchase up to 93,750 of the Sundance

Shares for a aggregate exercise price of $750,000 on March 31, 2015.


(D)         Certain of the companies that issued the Existing PDCs are in the process of changing management from the current managers (the "Current Managers") and Buyers are assisting in negotiations to remove such managers.


(E)

Sellers have agreed to amend the Agreement to provide for the payment of $375,000 of the exercise price on April 1, 2015 and the remaining $375,000 of the exercise price on the earlier of (i) three (3) calendar days after the execution of a term sheet providing for the removal of the Current Managers of the Existing PDCs or (ii) April 30, 2015.


THE PARTIES HEREBY AGREE AS FOLLOWS:


1.  Amendment.


1.1   Amendment  of Section 3.2(f). Section 3.2(f) of the Agreement, titled Cure Period, is hereby amended in its entirety to read as follows:


"f)  Cure Period.  In the event Buyer fails to timely pay the exercise price to Seller in connection with a properly exercised Put Option due to a lack of adequate liquidity, as determined in the Buyer's sole discretion, Buyer shall have the following Cure Periods:


(i)

With respect  to the First Exercise Date, prior to Seller exercising any Clawback Rights, (a) Buyer shall have thirty (30} calendar days from the receipt of an exercise notice to pay one-half of the exercise price in the amount  of $375,000 and (b) Buyer shall pay the balance of the exercise price in the amount of $375,000 on the earlier of (A) three (3) calendar days after the execution of a term sheet providing for the removal of the Current Managers of the Existing PDCs or (B) sixty (60) calendar days from the receipt of such exercise notice.


(ii)

With respect to the Second Exercise Date, prior to Seller exercising any Clawback  Rights, Buyer shall have forty-five (45) calendar days from the receipt of an exercise notice related to the Second Exercise Date, to pay the related exercise price."







1.2   No other Amendment. In all other respects. the Agreement is hereby ratified and confinned.


2

Counterparts.


This Amendment may be executed by the parties in separate counterparts, each of which when so executed shall be deemed to be an original and both of which when taken together shall constitute one and the same agreement.


IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed in counterparts as of the date first above written.



THE SELLER


HFII Assets Solutions




         /s/ Mark Niu

By: Mark Niu

Title: Manager



THE BUYER


Sundance Strategies,Inc.

[HFIIASSETTRANSFERAGREEMEN002.GIF]




DEBENTURE AGREEMENT


THIS DEBENTURE AGREEMENT (this “Agreement”) is made and entered into this 2nd day of June, 2015, by and among Sundance Strategies, Inc, a Nevada corporation (hereinafter referred to as the “Company”) and Satco International, Limited, an individual residing in Hong Kong, (hereinafter referred to as the “Lender”), on the following:


Premises


A.

Lender has engaged in preliminary discussions with the Company regarding providing interim financing to the Company through a debenture due in one year.


B.

The Company is interested in borrowing money from Lender on a short term, one year, period.


C.

The Company and Lender want to set forth their understanding as to the terms and conditions of the loan by Lender to the Company.


Agreement


BASED, upon the foregoing premises, which are incorporated herein by this reference, and for and in consideration of the mutual promises and covenants hereinafter set forth, and other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, it is agreed as follows:


ARTICLE I

LOAN


1.01

Loan .   Lender agrees to loan the Company and the Company agrees to borrow from Lender Seven Hundred Thousand dollars ($700,000.00) pursuant to the terms and conditions of the Debenture, attached hereto as exhibit “A” (the “Debenture”).  Lender shall loan the Company Seven Hundred thousand dollars ($700,000.00), all under the terms and conditions of this Agreement and the Debenture.  The term of the debenture shall be for a period of one year.


ARTICLE II

REPRESENTATIONS, COVENANTS, AND WARRANTIES

OF THE COMPANY


As an inducement to, and to obtain the reliance of Lender in connection with the Debenture, the Company represents and warrants as follows:


2.01

Private Offering .    The Debenture has not been and will not be registered with the Securities and Exchange Commission (the “Commission”).  The Debenture shall be entered into in reliance on exemptions from the registration requirements of Section 5 of the United States Securities Act of 1933, as amended, and as such, will be deemed “restricted securities” limiting the Debenture’s ability to be transferred.


2.02

Approval of Agreement .   The Company has full corporate power, authority, and legal right and has taken, or will take, all action required by law, its articles of incorporation, bylaws, and otherwise to





-1-


 


execute and deliver this Agreement and to consummate the transactions herein contemplated including entering into the Debenture.  The board of directors of the Company has authorized and approved the execution, delivery, and performance of this Agreement and the transactions contemplated hereby including entering into the Debenture.


2.03

Legal Right .  The performance of this Agreement and the consummation of the transactions herein contemplated will not result in a material breach or violation of any of the terms and provisions of, or constitute a default under, any statute (except federal and state securities laws, compliance with which is elsewhere provided for in particular detail), indenture, mortgage or other agreement or instrument to which the Company is a party or by which it is bound by any order, rule or regulation directed to the Company or its affiliates by any court or governmental agency or body having jurisdiction over them; and no other consent, approval, authorization or action is required for the consummation of the transactions herein contemplated other than such as have been obtained.


2.04

Validly Executed .   The Debenture will be duly authorized, validly and legally entered into and be a binding obligation on the part of the Company.


2.05

Organization .    The Company has been duly organized and is now a validly existing corporation under the laws of the state of Nevada lawfully qualified to conduct the business for which it was organized and which it proposes to conduct.  


ARTICLE III

REPRESENTATIONS, COVENANTS, AND WARRANTIES

OF THE LENDER


As an inducement to, and to obtain the reliance of the Company in connection with entering into the Debenture, Lender represents and warrants as follows:


3.01

Representations .   Lender is not relying on any representation or warranty of the Company, whatsoever, except those representations and warranties contained in this Agreement.


3.02

Standing and Authority of Lender .   Lender has all requisite power and authority to execute and deliver this Agreement, to perform Lender’s obligations hereunder and to consummate the transactions contemplated hereby.


3.03

Execution and Delivery; No Conflict .


(a)

This Agreement has been duly executed and delivered by the Lender and constitute the valid and binding obligation of Lender, enforceable against Lender in accordance with the terms herein, except as the same may be limited by:  (i) bankruptcy, insolvency, reorganization, moratorium or other laws affecting generally the enforcement of creditors’ rights; (ii) equitable principles; and (iii) public policies with respect to the enforcement of indemnification agreements.


(b)

The execution, delivery and performance of this Agreement by Lender and the consummation of the transactions contemplated hereby:  (i) have been duly and validly authorized by all necessary action on the part of Lender; and (ii) are not prohibited by, do not violate any provision of, and will not result in the breach of or accelerate or permit the acceleration of, the performance required by the terms of any applicable law, rule regulation, judgment, decree, order,





-2-



or other requirement of the United States or any state of the United States, or any court, authority, department, commission, board, bureau, agency, or instrumentality of either thereof in a manner which would have a material adverse effect on the Lender, or any material contract, indenture, agreement or commitment, to which the Lender is a party or bound.


3.04

Consents and Approvals .   The execution, delivery, and performance by Lender of this Agreement and the consummation by Lender of the transactions contemplated hereby do not require the Lender to obtain any consent, approval or action of, or give any notice to, any corporation, person, firm, or judicial authority except:  (i) such as have been duly obtained or made, as the case may be, and are in full force and effect on the date hereof; and (ii) those which the failure to obtain would have no material adverse effect on the transactions contemplated hereby.


3.05

Securities Representations .   Lender understands and agrees that the consummation of this Agreement including entering into the Debenture as contemplated hereby, constitutes the offer and sale of securities under the Securities Act.  Lender agrees that such transactions shall be consummated in reliance on exemptions from the registration and prospectus delivery requirements of such statutes which depend, among other items, on the circumstances under which such securities are acquired.  In order to provide documentation for reliance upon exemptions from the registration and prospectus delivery requirements for such transactions Lender will sign appropriate representations and warranties related to its suitability to invest in the Company, including an investment letter and suitability questionnaire which are contained in the “suitability letter” attached hereto as appendix “A.”  Lender understands that the Debenture and any shares of the Company received on conversion of the Debenture have not been registered under the Securities Act and must be held indefinitely without any transfer, sale, or other disposition unless such Debenture or shares are subsequently registered under the Securities Act or registration is not required under the Securities Act in reliance on an available exemption.  The Debenture and any shares on conversion of the Debenture to be received by the Lender under the terms of this Agreement will be acquired for the Lender’s own account, for investment, and not with the present intention of resale or distribution of all or any part of the securities.  Lender agrees that he will refrain from transferring or otherwise disposing of the Debenture, or any interest therein, in such manner as to violate the Securities Act or any applicable state securities law regulating the disposition thereof.  Lender is an “accredited investor” within the meaning of Regulation D promulgated under the Securities Act and has adequate means for providing for his current needs and possible personal contingencies and has no need now and anticipates no need in the foreseeable future to sell the Debenture or shares received on conversion of the Debenture or have the Debenture repaid prior to its maturity date.  Lender understands that Debenture is being entered into in reliance on specific exemptions from the registration requirements of Federal and state securities laws and that the Company is relying upon the truth and accuracy of Lender’s representations, warranties, agreements, and understandings set forth herein to determine Lender’s suitability to loan the Company the funds and accept the Debenture.


3.06

Disclosure Information .  Lender believes he has received all the information Lender considers necessary or appropriate for deciding whether or not to lend the Company money.  Lender further represents that he has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the loan.  The foregoing, however, does not limit or modify the representations and warranties of the Company in Article 2 of this Agreement or the right of Lender to rely thereon.  Lender is aware, through its due diligence review of the Company that the conversion price set forth in the Debenture for the shares of the Company’s common stock bear no relationship to assets, book value or other established criteria of determining value. Lender will further inform the Company of any discrepancies, error or disagreement between any representation, warranty, covenant or schedule of the Company or Lender based on Lender’s review of the due diligence information and discussions with the





-3-



Company or its management or has otherwise come to Lender’s attention and will provide such notice to the Company as soon as practicable after such discovery.


3.07

Investment Experience .  Lender is an investor in securities of companies in the development stage and acknowledges that he is able to fend for himself, can bare the economic risk of his investment and has such knowledge and experience in financial or business matters that he is capable of evaluating the merits and risks of loaning the Company money.


3.08

Acknowledgment .  Lender acknowledges that the Company has lost money, may not have the funds to pay the lender back the money loaned at the end of the Debenture period if the Company’s operations do not improve, that the Company’s operations are subject to the risks inherent in the establishment of new businesses, and that there can be no assurance that the Company will ever achieve profitability or that, if achieved, such profitability could be sustained.  Lender further acknowledges that a loan to the Company involves substantial risk and the potential loss of the funds being loaned. Additionally, Lender understands the Company will need to raise additional capital to pay off the Debenture when it matures.  Furthermore, any shares received on conversion of the Debenture will be restricted, may not be able to be resold and a trading market for such shares may not develop. Lender further acknowledges that and investment in the Debenture and the shares of common stock receivable on conversion of the Debenture involve substantial risk.


3.08

Knowledge of Company .  Lender is aware, through his own extensive due diligence of all material information respecting the past, present and proposed business operations of the Company, including, but not limited to, its technology, its management, its financial position, or otherwise including analyzing the Company’s filings with the Securities and Exchange Commission which include the Company’s annual and quarterly reports of Form 10-K and 10-Q and current reports on Form 8-K, and specifically reviewed the "risk factors" set forth in such reports including, but not limited to Part I, Item 1A.  Risk Factors (pages 22 through 36), of the 10-K Annual Report for the fiscal year ended March 31, 2014, and filed with the Securities and Exchange Commission on July 16, 2014, and as amended on July 21, 2014, and Lender also; understands that there is no “established trading market” for the Company’s Debentures or common stock receivable on conversion of the Debentures, that the Company is uncertain, at this time, whether there’re will be any future “established trading market” for the Company’s common stock.  Lender has conducted his own investigation of the risks and merits of an loan or investment in the Company, and to the extent desired, including, but not limited to a review of the Company’s books and records, financial statements and Lender has had the opportunity to discuss these documents with the directors and executive officers of the Company; to ask questions of these directors and executive officers; and that to the extent requested, all such questions have been answered to his satisfaction. Lender is familiar with and understands the business and financial condition, operations and prospects of the Company and is sufficiently informed and sophisticated enough to make a decision regarding the transactions contemplated by this Agreement.


3.09

Patriot Act .


(a)  Lender is not in violation of any legal requirements relating to terrorism or money laundering (“ Anti-Terrorism Laws ”), including Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001 (the “ Executive Order ”), and the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, Public Law 107-56 (the “ Patriot Act ”).






-4-



(b)  Lender, nor, to Lender’s Knowledge, any affiliate, stockholder or broker or other agent of Lender acting or benefiting in any capacity in connection with this Agreement is any of the following:


(i)

a person that is listed in the annex to, or is otherwise subject to the provisions of, the Executive Order;


(ii)

a person owned or controlled by, or acting for or on behalf of, any person that is listed in the annex to, or is otherwise subject to the provisions of, the Executive Order;


(iii)

a person with which any party is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law;


(iv)

a person that commits, threatens or conspires to commit or supports “terrorism” as defined in the Executive Order; or


(v)

a person that is named as a “specially designated national and blocked person” on the most current list published by OFAC at its official website or any replacement website or other replacement official publication of such list.


(c)

Lender, nor, to Lender’s Knowledge, any affiliate or stockholders or broker or other agent of Lender acting in any capacity in connection with this Agreement (i) conducts any business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any person described in Section 3.09(b), (ii) deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant to the Executive Order, or (iii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law.


ARTICLE IV

SPECIAL COVENANTS


4.01

Use of Funds .  All funds received will be used for general business purposes.


4.02

Access to Books and Records .  Until the closing date, the Company will afford to Lender and its authorized representatives full access to the properties, books, and records of the Company in order that Lender may have full opportunity to make such reasonable investigation as it shall desire to make of the affairs of the Company and will furnish the Lender with such additional financial and other information as to the business and properties of the Company as Lender shall from time to time reasonably request.


4.03

Private Offering .  The Company and Lender agree and understand that the consummation of this Agreement including the loan by Lender and execution of the Debenture as contemplated hereby, may constitutes the offer and sale of securities under the Securities Act and applicable state statutes.  The Company and Lender agree such transactions shall be consummated in reliance on exemptions from the registration and prospectus delivery requirements of such statutes which depend, among other items, on the circumstances under which such securities are acquired.






-5-



(a)

In order to provide documentation for reliance upon exemptions from the registration and prospectus delivery requirements for such transactions, the signing of this Agreement and the delivery of appropriate separate representations, including the “suitability letter” attached hereto as appendix “A” shall constitute the parties acceptance of, and concurrence in, the following representations and warranties:


(i)

Lender acknowledges that neither the SEC nor the securities commission of any state or other federal agency has made any determination as to the merits of the loan or Debenture, and that this transaction involves certain risks, including the possible loss of all funds loaned.


(ii)

Lender has received and read the Agreement and understand the risks related to the consummation of the transactions herein contemplated.


(iii)

Lender has such knowledge and experience in business and financial matters that he is capable of evaluating each business.


(iv)

Lender has been provided with copies of all materials and information requested by Lender or their representatives, including any information requested to verify any information furnished (to the extent such information is available or can be obtained without unreasonable effort or expense), and the parties have been provided the opportunity for direct communication regarding the transactions contemplated hereby.


(v)

All information which Lender has provided to the Company or their representatives concerning his suitability and intent to loan the Company funds is complete, accurate, and correct.


(vi)

Lender has not offered or sold any securities of the Company or interest in this Agreement and has no present intention of dividing the Debenture to be received or the rights under this Agreement with others or of reselling or otherwise disposing of any portion of such Debenture or rights, either currently or after the passage of a fixed or determinable period of time or on the occurrence or nonoccurrence of any predetermined event or circumstance.


(vii)

Lender understand that the Debenture has not been registered, but is being acquired by reason of a specific exemption under the Securities Act as well as under certain state statutes for transactions not involving any public offering and that any disposition of the subject Debenture may, under certain circumstances, be inconsistent with this exemption and may make Lender an “underwriter,” within the meaning of the Securities Act.  It is understood that the definition of “underwriter” focuses upon the concept of “distribution” and that any subsequent disposition of the subject Debenture can only be effected in transactions which are not considered distributions.  Generally, the term "distribution" is considered synonymous with “public offering” or any other offer or sale involving general solicitation or general advertising.  Under present law, in determining whether a distribution occurs when securities are sold into the public market, under certain circumstances one must consider the availability of public information regarding the issuer, a holding period for the securities sufficient to assure that the persons desiring to sell the securities without registration first bear the economic risk of their investment, and a





-6-



limitation on the number of securities which the stockholder is permitted to sell and on the manner of sale, thereby reducing the potential impact of the sale on the trading markets. These criteria are set forth specifically in rule 144 promulgated under the Securities Act.


(b)

In connection with the transaction contemplated by this Agreement, the Company and Lender shall each file, with the assistance of the other and their respective legal counsel, such notices, applications, reports, or other instruments as may be deemed by them to be necessary or appropriate in an effort to document reliance on such exemptions, and the appropriate regulatory authority in the states where Lender reside unless an exemption requiring no filing is available in such jurisdictions, all to the extent and in the manner as may be deemed by such parties to be appropriate.


(c)

In order to more fully document reliance on the exemptions as provided herein, the Company and Lender shall execute and deliver to the other, at or prior to the closing, such further letters of representation, acknowledgment, suitability, or the like as the Company or Lender and its counsel may reasonably request in connection with reliance on exemptions from registration under such securities laws including but not limited to an investment letter.


(d)

The Company and Lender acknowledge that the basis for relying on exemptions from registration or qualifications are factual, depending on the conduct of the various parties, and that no legal opinion or other assurance will be required or given to the effect that the transactions contemplated hereby are in fact exempt from registration or qualification.


ARTICLE V

MISCELLANEOUS


5.01

Attorney's Fees .  In the event that any party institutes any action or suit to enforce this Agreement or to secure relief from any default hereunder or breach hereof, the breaching party or parties shall reimburse the nonbreaching party or parties for all costs, including reasonable attorneys' fees, incurred in connection therewith and in enforcing or collecting any judgment rendered therein.


5.02

Entire Agreement .  This Agreement represents the entire agreement between the parties relating to the subject matter hereof.  All previous agreements between the parties, whether written or oral, have been merged into this Agreement.  This Agreement alone fully and completely expresses the agreement of the parties relating to the subject matter hereof.  There are no other courses of dealing, understandings, agreements, representations, or warranties, written or oral, except as set forth herein.


5.03

Survival; Termination .  The representations, warranties, and covenants of the respective parties shall survive the closing and the consummation of the transactions herein contemplated for a period of six months from the closing, unless otherwise provided herein.


5.04

Counterparts .  This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which taken together shall be but a single instrument.


5.05

Amendment or Waiver .  Every right and remedy provided herein shall be cumulative with every other right and remedy, whether conferred herein, at law, or in equity, and such remedies may be enforced concurrently, and no waiver by any party of the performance of any obligation by the other shall be construed as a waiver of the same or any other default then, theretofore, or thereafter occurring or existing.  





-7-



At any time prior to the closing, this Agreement may be amended by a writing signed by all parties hereto, with respect to any of the terms contained herein, and any term or condition of this Agreement may be waived or the time for performance thereof may be extended by a writing signed by the party or parties for whose benefit the provision is intended.


5.06

Binding Effect .  This Agreement shall inure to the benefit of and be binding upon the Company and Lender and their successors.  Nothing expressed in this Agreement is intended to give any person other than the persons mentioned in the preceding sentence any legal or equitable right, remedy or claim under this Agreement.


5.07

Severability .  Every provision of this Agreement is intended to be severable.  If any term or provision hereof is illegal or invalid for any reason whatsoever, such illegality or invalidity shall not affect the validity of the remainder hereof.


5.08

Captions .  The captions or headings in this Agreement are inserted for convenience and identification only and are not intended to describe, interpret, define, or limit the scope, extent, or intent of this Agreement or any provisions hereof.


5.09

Applicable Law .  The Company and Lender hereby agree that this Agreement shall be governed by and construed and enforced under and in accordance with the laws of the State of Utah, where the Company’s corporate office reside. without reference to conflict of laws and all subject matter and in persona jurisdiction shall be the state courts of Utah and as such the Company and Lender irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the courts of the State of Utah and of the United States of America located in Utah for any actions, suits or proceedings arising out of or relating to this Agreement and the Company and Lender agree not to commence any action, suite or proceedings relating thereto except in such courts.


IN WITNESS WHEREOF, the corporate parties hereto have caused this Agreement to be executed by their respective officers, hereunto duly authorized, as of the date first above written.


THE COMPANY:

THE LENDER:

Sundance Strategies, Inc.

Satco International, Limited

a Nevada corporation


By: /s/ Randall Pearson___________

/s/Stephen H. Smoot __________

     A Duly Authorized Officer

Stephen H. Smoot, Attorney-in-Fact

     It's President






-8-



Appendix A


SUITABILITY LETTER


TO:

__________________


I make the following representations with the intent that they may be relied on by __________________ (the "Company").  


1.

I have had the opportunity to ask questions of, and receive answers and information, from the officers of the Company and I deemed such information sufficient to make an investment decision on the Company.


2.

I have such knowledge and experience in business and financial matters that I am capable of evaluating the Company, its business activities, and the risks and merits of this prospective investment, and I am not utilizing a purchaser representative (as defined in regulation D) in connection with the evaluation of such risks and merits, except the following:   


3.

I shall provide a separate written statement from each purchaser representative on the Purchaser Representative Acknowledgment form available from the Company in which is disclosed (i) the relationship of the purchaser representative with the Company, if any, which has existed at any time during the previous two years, and compensation received or to be received as a result of such relationship, and (ii) the education, experience, and knowledge in financial and business matters which enables the purchaser representative to evaluate the relative merits and risks of an investment in the Company.  


4.

The undersigned and the purchaser representatives listed above together have such knowledge and experience in financial and business matters that they are capable of evaluating the Company and the proposed activities thereof and the merits and risks of this prospective investment.  


5.

I have adequate means of providing for my current needs and possible personal contingencies and have no need in the foreseeable future for liquidity of an investment in the Company.  


6.

Instructions:  Complete either (a) or (b) below, as applicable:


(a)       FOR ACCREDITED INVESTORS .  I confirm that I am an "accredited investor" as defined under rule 501 of regulation D promulgated under the Securities Act of 1933, as amended (the "Securities Act"), as checked below:  


(i)

Any bank as defined in section 3(a)(2) of the Securities Act or any savings and loan association or other institution as defined in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity; any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; any insurance company as defined in section 2(13) of the Securities Act; any investment company registered under the Investment Company Act of 1940 or a business development company as defined in section 2(a)(48) of that Act; any small business investment company licensed by the U. S. Small Business Administration under section 301(c) or (d) of the Small Business Investment Act of 1958; any plan established and maintained by a state, its political subdivisions,



D-1



 or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors;

o

Yes

o

No


(ii)

Any private business development company as defined in section 302(a)(22) of the Investment Advisers Act of 1940;

o

Yes

o

No


(iii)

Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

o

Yes

o

No


(iv)

Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer, or general partner of a general partner of that issuer;

o

Yes

o

No


(v)

Any natural person whose individual net worth, or joint net worth with that person's spouse, at the time of his or her purchase exceeds $1,000,000, excluding the value of the primary residence of such person;

o

Yes

o

No


For purposes of category (v), the term "net worth" means the excess of total assets over total liabilities.  


(vi)

Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person's spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year;

o

Yes

o

No


In determining income, the undersigned should add to his or her adjusted gross income any amounts attributable to tax exempt income received, losses claimed as a limited partner in any limited partnership, deductions claimed for depletion, contributions to an IRA or Keogh retirement plan, alimony payments, and any amount by which income from long-term capital gains has been reduced in arriving at adjusted gross income.


(vii)

Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in section 230.506(b)(2)(ii); and

o

Yes

o

No



D-2




(viii)

Any entity in which all of the equity owners are accredited investors.  

o

Yes

o

No


(b)

FOR NONACCREDITED INVESTORS .  I am not an accredited investor.


The following information is being provided here in lieu of furnishing a personal financial statement.


(i)

My net worth excluding principal residence, furnishings, and automobiles is at least _____ times the total investment I intend to make in the Company;


(ii)

My annual disposable income, after excluding all of my personal and family living expenses and other cash requirements for current obligations, is such that the loss of my entire investment in the Company would not materially alter my standard of living;

o

Yes

o

No


(iii)

Considering the foregoing and all other relevant factors in my financial and personal circumstances, I am able to bear the economic risk of an investment in the Company.

o

Yes

o   No


7.

I have previously been advised that I would have an opportunity to review all the pertinent facts concerning the Company, and to obtain any additional information which I might request, to the extent possible or obtainable, without unreasonable effort and expense, in order to verify the accuracy of the information provided me.  


8.

I have personally communicated or been offered the opportunity to communicate with executive officers of the Company to discuss the business and financial affairs of the Company, its products and activities, and its plans for the future.  I acknowledge that if I would like to further avail myself of the opportunity to ask additional questions of the Company, the Company will make arrangements for such an opportunity on request.  


9.

I have been advised that no accountant or attorney engaged by the Company is acting as my representative, accountant, or attorney.  



D-3




10.

I will hold title to my interest as follows:  

o

Community Property

o

Separate Property

o

Joint Tenants, with Right of

o

Tenants in Common

Survivorship

o

Other (Single Person, Trust, Etc., Please

                                                                               Indicate.)



11.

I am a bona fide citizen of Japan and maintain my full time domicile in Japan.  The address below is my true and correct principal residence.  


DATED this 4 th day of September, 2013.  



Name (Please Print)

Name of Joint Subscriber, If Any



Signature

Signature



Street Address

Street Address



City, State, and Zip Code

City, State, and Zip Code



D-4


Exhibit A

Debenture


Date:   June 2, 2015

    Amount: $700,000,000 (U.S.)


___________________________

CONVERTIBLE DEBENTURE

BEARING INTEREST AT 8% PER ANNUM

______________________________________________________________________________


THIS DEBENTURE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES.  THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE TRANSFERRED OR SOLD IN THE ABSENCE OF AN EFFECTIVE REGISTRATION OR OTHER COMPLIANCE UNDER THE SECURITIES ACT OR THE LAWS OF THE APPLICABLE STATE OR A "NO-ACTION" OR INTERPRETIVE OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT THE SALE OR TRANSFER IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND SUCH STATE STATUTES.

______________________________________________________________________________


Sundance Strategies, Inc., a corporation duly organized and existing under the laws of the State of Nevada (hereinafter referred to as the "Company"), for value received, hereby promises to pay to Satco International, Limited , the registered holder hereof, the principal sum of Seven Hundred Thousand, United States Dollars (U.S. $700,000.00) one (1) year from date, upon presentation and surrender of this Debenture (the "Debenture") at the offices of the Company, in such lawful money of the United States of America as at the time of payment shall be legal tender for the payment of public and private debt, until the principal hereof is paid or made available for payment as herein provided.


This Debenture is subject to the following further terms and material provisions:


1.

Series .

This Debenture is one of a duly authorized series of Debentures of the Company totaling two million dollars ($2,000,000) (the “Debentures”).


2.

Term and Interest .  The date of maturity of the Debenture shall be one (1) year from the date of issuance, subject to prepayment as set forth in paragraph 3 hereof.  The Debenture shall bear simple interest at the rate of eight percent (8%) per annum.  The principal on the Debenture is payable on the maturity date, subject to prepayment as set forth in paragraph 3 hereof, and will be paid at the office of the Company, maintained for such purposes, to the registered holder of the Debenture on the books and records of the Company.  Accrued interest on the Debenture will be payable annually, on the anniversary date of the Debenture, and will be paid at the office of the Company, maintained for such purposes, to the registered holder of the Debenture on the books and records of the Company.


3.

Prepayment .  Subject to the provisions of Section 7 hereof and the right of the Holder to convert this Debenture prior to payment, this Debenture is subject to prepayment, in



-1-



whole or in part, at the election of the Company at any time, upon not less than 10 days’ notice. Prepayment shall be effected by paying the amount equal to the outstanding principal amount of the Debenture and accrued interest at the date of prepayment.  On the date fixed for prepayment by the Company, the amount of principal shall be paid in cash or certified funds.  Any Debenture which is prepaid only in part shall be presented for notation thereon by the Company of such partial prepayment.  If less than all the Debenture principal amount and interest is to be prepaid, notice of the proposed prepayment shall be sent to the registered holder of the Debenture and such prepayment shall be made.


4.

Satisfaction and Discharge of Debenture .  This Debenture shall cease to be of further effect (except as to any surviving rights of transfer, or exchange of Debentures herein expressly provided for) when:


(a)

The Company has paid or caused to be paid all sums payable hereunder by the Company, including all principal and interest amounts under the Debenture or the conversion of the Debenture as provided herein; and


(b)

All the conditions precedent herein provided for relating to the satisfaction and discharge of this Debenture have been met.


5.

Events of Default .  "Events of Default," when used herein, whatever the reason for such event of default and whether it shall be voluntary or involuntary or be effected by operation of law pursuant to any judgment, decree, or order of any court or any order, rule, or regulation of any administrative or government body or be caused by the provisions of any paragraph herein means any one of the following events:


(a)

Default in the payment of the principal of the Debenture, when due, whether at maturity, or otherwise; or


(b)

Default in the performance or breach of any covenant or warranty of the Company in this Debenture (other than a covenant or warranty, the breach or default in performance of which is elsewhere in this section specifically dealt with), and continuation of such default or breach for a period of 30 days after there has been given to the Company by registered or certified mail, by the holders of a majority in principal amount of the outstanding Debenture, a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a notice of default hereunder; or


(c)

The entry of a decree or order by a court having jurisdiction in the premises adjudging the Company a bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment, or composition of or in respect of the Company under the Federal Bankruptcy Act or any other applicable federal or state law, or appointing a receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of the Company or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuation of any such decree or order unstayed and in effect for a period of 30 consecutive days; or


(d)

The institution by the Company of proceedings to be adjudicated a bankrupt or insolvent, or the consent by it to the institution of bankruptcy or insolvency proceedings against it, or a filing by it of a petition or answer or consent seeking



-2-



reorganization or relief under the Federal Bankruptcy Act or any other applicable federal or state law; or


(e)

The consent by the Company to the filing of any such petition or the appointment of a receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of the Company or of any substantial part of its property), or the making by it of an assignment for the benefit of creditors, or the admission by it in writing of its inability to pay its debts generally as they become due, or the taking of corporate action by the Company in furtherance of any such action.


6.

Acceleration of Maturity .  If an event of default occurs and is continuing then, in every such case, the holder of a majority in principal amount of the outstanding Debentures, may declare the principal of the Debentures to be due and payable immediately, by a notice in writing to the Company of such default, and upon any such declaration, such principal shall become immediately due and payable.  At any time after such declaration of acceleration has been made, and before a judgment or decree for payment of money due has been obtained by the holders, the holders of a majority of the principal of the outstanding Debentures, by written notice to the Company, may rescind and annul such declaration and its consequences, if all events of default, other than the nonpayment of the principal of the Debentures which has become due solely by such acceleration, has been cured or waived.  No such recession shall affect any subsequent default or impair any right contingent thereon.


7.

Conversion .  Subject to, and in compliance with, the provisions contained herein, the Holder of this Debenture is entitled, at its or his option, one year from the date of issuance, or in case this Debenture or some portion hereof shall have been called for prepayment or considered in default under paragraph 5 hereof, then, in respect of this Debenture or such portion hereof, to convert this Debenture (or any portion of the principal amount hereof), into validly issued, fully paid and nonassessable restricted shares (calculated as to each conversion to the nearest share) of common stock, $0.001 per share of the Company, (the “Common Stock” or “Shares”) where the conversion price shall be equal to ninety percent (90%) of the CAP of the Company’s common stock (“Conversion Price”), as defined herein, subject to such adjustment in such Conversion Price, if any, as may be required by the provisions of this Debenture, by surrender of this Debenture, duly endorsed (if so required by the Company) or assigned to the Company or in blank, to the Company at its offices, accompanied by written notice to the Company, that the Holder hereof elects to convert this Debenture or, if less than the entire principal amount hereof is to be converted, the portion hereof to be converted.  The number of Shares issuable upon a conversion hereunder shall be determined by the quotient obtained by dividing (x) the outstanding principal amount, including any accrued but unpaid dividends, of this Debenture to be converted by (y) the Conversion Price. On conversion, no adjustment for interest is to be made, but if any Holder surrenders this Debenture for conversion between the record date for the payment of any installment of interest and the next interest payment date, the holder of such Debenture when surrendered for conversion shall be entitled to payment of the interest thereon from the last preceding record date for interest through the date of conversion which the registered holder is entitled to receive on such conversion date.  No fraction of Shares will be issued on conversion, but instead of any fractional interest, the Company will pay cash adjustments as provided herein. Following receipt of the written notice of intention to convert the Debenture, the Company shall take such steps as it deems appropriate to permit conversion of the Debenture as specified herein without registration or qualification under applicable federal and state securities laws.  “ CAP ” means, for any date, the ninety (90) day average closing price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the average closing price of the Common Stock for the prior ninety (90) days from the date the notice of conversion was received (or the nearest



-3-



date) on the Trading Market on which the Common Stock is then listed or quoted for trading as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)); (b) if the Common Stock is not then quoted for trading on the OTCQB or other Trading Market and if prices for the Common Stock are then reported in the “Pink Sheets” published by Pink Sheets, LLC (or a similar organization or agency succeeding to its functions of reporting prices or as reported on other electronic quotation system), the ninety (90) day average closing price or if no closing price the bid price per share of the Common Stock so reported; or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company.  “Trading Market” means the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the American Stock Exchange, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the OTCQB.  If no closing price is listed, the bid price shall be used as the closing price.


8.

Suits for Enforcement .  If an event of default occurs and is continuing, the holder of a majority in principal amount of the outstanding Debenture may, in their discretion, proceed to protect and enforce their rights by such appropriate judicial proceedings as the holders shall deem most effectual to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement under this Debenture or in aid of the exercise of any power granted herein, or to enforce any other proper remedy.


9.

Limitation on Suits .  No holder of any Debenture shall have any right to institute any proceedings, judicial or otherwise, with respect to this Debenture, or for the appointment of a receiver or trustee, or for any remedy hereunder, unless such holder has previously given written notice to the Company of a continuing event of default as provided above; it being understood and intended that no one or more holders of this Debenture shall have any right in any manner whatever by virtue of, or by availing of, any provisions of this Debenture to effect, disturb or prejudice the right of any other holders of Debentures, or to obtain or to seek to obtain priority or preference over any other holders or to enforce any right under this Debenture, except in the manner herein provided and for the equal and ratable benefit of all the holders of the Debenture.


10.

Acts of Holders .  Any request, demand, authorization, direction, notice, consent, waiver, or other action provided by this Debenture to be given or taken by the holder hereof or by the holders of the Debentures may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such holders in person or by their agent or attorney-in-fact, duly appointed in writing; and, except as otherwise expressly provided herein, such action shall become effective when such instrument or instruments are delivered to the Company in the manner provided for giving notices herein.  Such instrument or instruments, and the action embodied therein or evidenced thereby, are herein sometimes referred to as the “act” of the holders signing such instrument or instruments.  Proof of execution of any such instrument or of writing appointing any such agent shall be sufficient for any purpose of this Debenture if the fact and date of execution by any person of any purpose of the Debenture if the fact and date of execution by any person of any such instrument or writing is verified by the affidavit of a witness of such execution or by the request, demand, authorization, direction, notice, consent, waiver, or other action by the holder of this Debenture shall bind every Debenture holder of the same Debenture and the holder of every Debenture issued upon the transfer thereof or in exchange therefor or in lieu thereof in respect of anything done or suffered to be done by any person in reliance thereon, whether or not notation of such action is made upon such Debenture.




-4-



11.

Notices to Holders; Waiver .  Where this Debenture provides for notice to holders of any event, such notice shall be sufficiently given if in writing and sent by courier providing for delivery within 72 hours or mailed, registered, postage prepaid, to each holder affected by such event, at his address as it appears in the Debenture register maintained by the Company, not later than the latest date, and not earlier than the earliest date, prescribed for the giving of such notice. Where the Debenture provides for notice to the Company, such notice shall be sufficiently given if in writing and mailed, registered, postage prepaid, to the Company at its address set forth above (or at such other address as shall be provided to the holder of this Debenture in the manner for giving notices set forth herein), not later than the latest date, and not earlier than the earliest date, prescribed for the giving of such notice.  Where this Debenture provides for notice in any manner, such notice may be waived in writing by the person entitled to receive such notice, whether before or after the event, any such waiver shall be equivalent of such notice.


12.

Restrictions .  The holder of this Debenture, by acceptance hereof, represents and warrants as follows:


(a)

The Debenture is being acquired for the holder's own account to be held for investment purposes only and not with a view to, or for, resale in connection with any distribution of such Debenture or any interest therein without registration or other compliance under the Securities Act and applicable state securities laws, and the holder hereof has no direct or indirect participation in any such undertaking or in underwriting such an undertaking.


(b)

The holder hereof has been advised and understands that the Debenture and any Shares received through the conversion of this Debenture, have not been registered under the Securities Act and the Debenture and any Shares received upon conversion must be held and may not be sold, transferred, or otherwise disposed of for value unless it is subsequently registered under the Securities Act or an exemption from such registration is available; except as set forth herein, the Company is under no obligation to register the Debenture or the Shares of Common Stock received upon conversion under the Securities Act; in the absence of such registration, sale of the Debenture or the Shares may be impracticable; the Company will maintain stop-transfer orders against registration of transfer of the Debenture and the Shares.  The Company may refuse to transfer the Debenture or the Shares unless the holder thereof provides an opinion of legal counsel reasonably satisfactory to the Company or a "no-action" or interpretive response from the Securities and Exchange Commission to the effect that the transfer is proper; further, unless such letter or opinion states that the Debenture or the Shares are free from any restrictions under the Securities Act, the Company may refuse to transfer the Debenture or the Shares to any transferee who does not furnish in writing to the Company the same representations and agree to the same conditions with respect to such Debenture or the Shares if any set forth herein.  The Company may also refuse to transfer the Debenture or the Shares if any circumstance is present reasonably indicating that the transferee's representations are not accurate.


13.

Severability .  In case any provision in this Debenture shall be invalid, illegal, or unenforceable, the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.


14.

Governing Law .  This Debenture shall be governed by and construed and interpreted in accordance with the laws of the State of Nevada and without reference to conflict of laws and all subject matter and in persona jurisdiction shall be the state courts of Utah where the Company has its headquarters, and as such Holder and the Company irrevocably and



-5-



unconditionally consent to submit to the exclusive jurisdiction of the courts of the State of Utah and of the United States of America located in Utah for any actions, suits or proceedings arising out of or relating to this Debenture and Holder and the Company agree not to commence any action, suite or proceedings relating thereto except in such courts.


15.

Legal Holidays .  In any case where any date provided herein shall not be a business day, then (notwithstanding any other provision of this Debenture) the event required or permitted on such date shall be required or permitted, as the case may be, on the next succeeding business day with the same force and effect as if made on the date upon which such event was required or permitted pursuant hereto.


16.

Delay or Omission; No Waiver .  No delay or omission of any holder of the Debenture to exercise any right or remedy accruing upon any event of default shall impair any such right or remedy or constitute a waiver of any such event or default or any acquiescence therein.  Every right or remedy given hereby or by law may be from time to time, and as often as may be deemed expedient.


17.

Miscellaneous .  This Debenture is subject to the following additional terms and conditions:


(a)

If this Debenture is placed with any attorney for collection, or if suit be instituted for collection, or if any other remedy provided by law is pursued by the registered holder hereof, because of any default in the terms and conditions herein, then in either event, the undersigned agrees to pay reasonable attorneys' fees, costs, and other expenses incurred by the registered holder here of in so doing.


(b)

None of the rights and remedies of the registered holder hereof shall be waived or affected by failure or delay to exercise them.  All remedies conferred on the registered holder of this Debenture shall be cumulated and none is exclusive.  Such remedies may be exercised concurrently or consecutively at the registered holder's option.


(c)

This Debenture is negotiable and transferable, subject to compliance with the provisions of paragraph 12 hereof.


(d)

The makers, guarantors, and endorsers hereof severally waive presentment for payment, protest, and notice of protest, and of nonpayment of this Debenture.


(e)

This Debenture may not be sold to any US Person and is to be sold only to persons not domiciled in or located within the United States.


DATED effective as of the 2nd day of June, 2015.


SUNDANCE STRATEGIES, INC



By: /s/ Randall Pearson______

     A Duly Authorized Officer

     It's President



-6-


[RADIANTLIFE630KLOC2015033001.JPG]




[RADIANTLIFE630KLOC2015033002.JPG]




[RADIANTLIFE630KLOC2015033003.JPG]




[RADIANTLIFE630KLOC2015033004.JPG]



Exhibit 31-1

  

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

  

I, Randall F. Pearson, certify that:

  

1.   I have reviewed this Quarterly Report on Form 10-Q of Sundance Strategies, Inc.;

  

2.   Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

  

3.   Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Quarterly Report;

  

4.   The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Registrant and have:

  

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

  

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)

evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Quarterly Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Quarterly Report based on such evaluation; and

  

d)

disclosed in this Quarterly Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

  

5.   The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions);

  

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

  

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.



Date:

August 10, 2015

  

By:

/s/Randall F. Pearson

  

  

  

  

Randall F. Pearson, President & CEO







Exhibit 31-2

  

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

  

I, Randall F. Pearson, certify that:

  

1.   I have reviewed this Quarterly Report on Form 10-Q of Sundance Strategies, Inc.;

  

2.   Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

  

3.   Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Quarterly Report;

  

4.   The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Registrant and have:

  

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

  

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)

evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Quarterly Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Quarterly Report based on such evaluation; and

  

d)

disclosed in this Quarterly Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

  

5.   The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions);

  

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

  

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.



Date:

August 10, 2015

  

By:

/s/Randall F. Pearson

  

  

  

  

Randall F. Pearson, Acting CFO







Exhibit 32



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report of Sundance Strategies, Inc. (the “Registrant”) on Form 10-Q for the period ending June 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Randall F. Pearson, President, CEO and acting CFO of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1) The Quarterly Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.


Date:

August 10, 2015

  

By:

/s/Randall F. Pearson

  

  

  

  

Randall F. Pearson, President, CEO and acting CFO